;PatientID;cohort;histological_type;ER.Status;PR.Status;HER2.Final.Status;methylation.Clusters;Integrated.Clusters.with.PAM50.;pathologic_M;pathologic_T;pathologic_N;pathologic_stage;age;gender;overall_survival;overall_survival_months;days_to_death;days_to_last_followup;disease_status;disease_free_months
1;TCGA-3C-AAAU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
2;TCGA-3C-AALI;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
3;TCGA-3C-AALJ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
4;TCGA-3C-AALK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
5;TCGA-4H-AAAK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
6;TCGA-5L-AAT0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
7;TCGA-5L-AAT1;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
8;TCGA-5T-A9QA;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;NX;stage I;52;FEMALE;Alive;0.39;NA;12;DiseaseFree;0.39
9;TCGA-A1-A0SB;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;5;NA;M0;T1;N0;stage I;70;FEMALE;Alive;8.51;NA;259;DiseaseFree;8.51
10;TCGA-A1-A0SD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T2;N0;stage II;59;FEMALE;Alive;14.36;NA;437;DiseaseFree;14.36
11;TCGA-A1-A0SE;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;56;FEMALE;Alive;43.4;NA;1321;DiseaseFree;43.4
12;TCGA-A1-A0SF;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;54;FEMALE;Alive;48.06;NA;1463;DiseaseFree;48.06
13;TCGA-A1-A0SG;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;61;FEMALE;Alive;14.26;NA;434;DiseaseFree;14.26
14;TCGA-A1-A0SH;TCGA Breast Carcinoma;Luminal A;Negative;Positive;Negative;2;1;M0;T2;N0 ;stage II;39;FEMALE;Alive;47.21;NA;1437;DiseaseFree;47.21
15;TCGA-A1-A0SI;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T2;N1;stage II;52;FEMALE;Alive;20.86;NA;635;DiseaseFree;20.86
16;TCGA-A1-A0SJ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N1;stage III;39;FEMALE;Alive;13.67;NA;416;DiseaseFree;13.67
17;TCGA-A1-A0SK;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;54;FEMALE;Dead;31.77;967;NA;NA;NA
18;TCGA-A1-A0SM;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;4;NA;M0;T2;N0 ;stage II;77;MALE;Alive;7.95;NA;242;DiseaseFree;7.95
19;TCGA-A1-A0SN;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;MX;T1;N1;stage II;50;FEMALE;Alive;39.29;NA;1196;DiseaseFree;39.29
20;TCGA-A1-A0SO;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;67;FEMALE;Alive;27.99;NA;852;DiseaseFree;27.99
21;TCGA-A1-A0SP;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;NA;NA;M0;T2;N0 ;stage II;40;FEMALE;Alive;19.19;NA;584;DiseaseFree;19.19
22;TCGA-A1-A0SQ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T2;N1;stage II;45;FEMALE;Alive;18.2;NA;554;DiseaseFree;18.2
23;TCGA-A2-A04N;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0 ;stage I;66;FEMALE;Alive;104.73;NA;3153;DiseaseFree;104.73
24;TCGA-A2-A04P;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N3;stage III;36;FEMALE;Dead;18;548;NA;Recurred/Progressed;5.91
25;TCGA-A2-A04Q;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;1;3;M0;T1;N0 ;stage I;48;FEMALE;Alive;78.35;NA;1276;DiseaseFree;78.35
26;TCGA-A2-A04R;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T1;N0 ;stage I;36;FEMALE;Alive;82.1;NA;2365;DiseaseFree;82.1
27;TCGA-A2-A04T;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;62;FEMALE;Alive;73.78;NA;1950;DiseaseFree;73.78
28;TCGA-A2-A04U;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;47;FEMALE;Alive;48.82;NA;671;DiseaseFree;48.82
29;TCGA-A2-A04V;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;39;FEMALE;Dead;63.07;1920;NA;Recurred/Progressed;48.29
30;TCGA-A2-A04W;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;NA;M0;T2;N1;stage II;50;FEMALE;Alive;63.99;NA;1918;DiseaseFree;63.99
31;TCGA-A2-A04X;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;1;NA;M0;T2;N0 ;stage II;34;FEMALE;Alive;55.39;NA;1349;DiseaseFree;55.39
32;TCGA-A2-A04Y;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N1;stage II;53;FEMALE;Alive;36.1;NA;764;DiseaseFree;36.1
33;TCGA-A2-A0CK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N2;stage III;60;FEMALE;Alive;125.49;NA;3820;DiseaseFree;125.49
34;TCGA-A2-A0CL;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;1;1;M0;T3;N2;stage III;37;FEMALE;Alive;64.52;NA;1827;DiseaseFree;64.52
35;TCGA-A2-A0CM;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;4;2;M0;T2;N0 ;stage II;40;FEMALE;Dead;24.77;754;NA;Recurred/Progressed;12.55
36;TCGA-A2-A0CO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0;stage II;85;FEMALE;Dead;114.72;NA;3409;NA;NA
37;TCGA-A2-A0CP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0 ;stage I;60;FEMALE;Alive;92.41;NA;2495;DiseaseFree;92.41
38;TCGA-A2-A0CQ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0 ;stage I;62;FEMALE;Alive;88.53;NA;2393;DiseaseFree;88.53
39;TCGA-A2-A0CR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0;stage II;54;FEMALE;Alive;107.85;NA;2955;DiseaseFree;107.85
40;TCGA-A2-A0CS;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M1;T4;N3;stage IV;73;FEMALE;Alive;75.49;NA;2298;DiseaseFree;75.49
41;TCGA-A2-A0CT;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;4;M0;T2;N0 ;stage II;71;FEMALE;Alive;75.2;NA;1918;DiseaseFree;75.2
42;TCGA-A2-A0CU;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;73;FEMALE;Dead;5.19;158;NA;NA;NA
43;TCGA-A2-A0CV;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;41;FEMALE;Alive;63.4;NA;1870;DiseaseFree;63.4
44;TCGA-A2-A0CW;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;67;FEMALE;Alive;63.99;NA;1750;DiseaseFree;63.99
45;TCGA-A2-A0CX;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;4;NA;M0;T2;N0 ;stage II;52;FEMALE;Alive;56.77;NA;1303;DiseaseFree;56.77
46;TCGA-A2-A0CY;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;5;NA;M0;T2;N1;stage II;63;FEMALE;Alive;54.96;NA;1288;DiseaseFree;54.96
47;TCGA-A2-A0CZ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;46;FEMALE;Alive;53.09;NA;1339;DiseaseFree;53.09
48;TCGA-A2-A0D0;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;60;FEMALE;Alive;21.12;NA;643;DiseaseFree;21.12
49;TCGA-A2-A0D1;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;3;1;M0;T2;N0 ;stage II;76;FEMALE;Alive;34.53;NA;786;DiseaseFree;34.53
50;TCGA-A2-A0D2;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;45;FEMALE;Alive;33.74;NA;761;DiseaseFree;33.74
51;TCGA-A2-A0D3;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0 ;stage I;42;FEMALE;Alive;28.75;NA;736;DiseaseFree;28.75
52;TCGA-A2-A0D4;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N1;stage II;37;FEMALE;Alive;25.2;NA;496;DiseaseFree;25.2
53;TCGA-A2-A0EM;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0 ;stage I;73;FEMALE;Alive;101.64;NA;2758;DiseaseFree;101.64
54;TCGA-A2-A0EN;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T2;N0 ;stage II;70;FEMALE;Alive;89.29;NA;2516;DiseaseFree;89.29
55;TCGA-A2-A0EO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0 ;stage I;54;FEMALE;Alive;80.22;NA;2181;DiseaseFree;80.22
56;TCGA-A2-A0EP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0 ;stage I;56;FEMALE;Alive;107.52;NA;3021;DiseaseFree;107.52
57;TCGA-A2-A0EQ;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;4;M0;T2;N0 ;stage II;64;FEMALE;Alive;79.7;NA;2053;DiseaseFree;79.7
58;TCGA-A2-A0ER;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T1;N1;stage I;63;FEMALE;Alive;74.34;NA;1903;DiseaseFree;74.34
59;TCGA-A2-A0ES;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;52;FEMALE;Alive;37.02;NA;1001;DiseaseFree;37.02
60;TCGA-A2-A0ET;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N2;stage III;58;FEMALE;Alive;35.02;NA;807;DiseaseFree;35.02
61;TCGA-A2-A0EU;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0 ;stage I;79;FEMALE;Alive;34.26;NA;733;DiseaseFree;34.26
62;TCGA-A2-A0EV;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0 ;stage I;80;FEMALE;Alive;31.8;NA;545;DiseaseFree;31.8
63;TCGA-A2-A0EW;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N3;stage III;53;FEMALE;Alive;29.73;NA;770;DiseaseFree;29.73
64;TCGA-A2-A0EX;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N0 ;stage II;46;FEMALE;Alive;24.7;NA;550;DiseaseFree;24.7
65;TCGA-A2-A0EY;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;4;4;M0;T2;N1;stage II;62;FEMALE;Alive;24.15;NA;485;DiseaseFree;24.15
66;TCGA-A2-A0ST;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N1;stage II;62;FEMALE;Alive;99.11;NA;1643;DiseaseFree;99.11
67;TCGA-A2-A0SU;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;66;FEMALE;Alive;54.6;NA;1352;DiseaseFree;54.6
68;TCGA-A2-A0SV;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M1;T2;N2;stage IV;63;FEMALE;Dead;27.1;825;NA;Recurred/Progressed;1.58
69;TCGA-A2-A0SW;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;4;M1;T2;N2;stage IV;82;FEMALE;Dead;44.84;1365;NA;Recurred/Progressed;21.45
70;TCGA-A2-A0SX;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0 ;stage I;48;FEMALE;Alive;50.39;NA;1288;Recurred/Progressed;40.7
71;TCGA-A2-A0SY;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;4;NA;M0;T3;N1;stage III;62;FEMALE;Alive;44.25;NA;1154;DiseaseFree;44.25
72;TCGA-A2-A0T0;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;59;FEMALE;Alive;17.51;NA;337;DiseaseFree;17.51
73;TCGA-A2-A0T1;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;5;1;M0;T3;N3;stage III;55;FEMALE;Alive;17.12;NA;323;DiseaseFree;17.12
74;TCGA-A2-A0T2;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M1;T3;N3;stage IV;66;FEMALE;Dead;8.38;255;NA;Recurred/Progressed;2.56
75;TCGA-A2-A0T3;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T1;N1;stage I;37;FEMALE;Alive;18.69;NA;456;DiseaseFree;18.69
76;TCGA-A2-A0T4;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;3;M0;T2;N0 ;stage II;62;FEMALE;Alive;20.5;NA;395;DiseaseFree;20.5
77;TCGA-A2-A0T5;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0 ;stage II;39;FEMALE;Alive;17.44;NA;321;DiseaseFree;17.44
78;TCGA-A2-A0T6;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N0 ;stage II;50;FEMALE;Alive;18.89;NA;344;DiseaseFree;18.89
79;TCGA-A2-A0T7;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;51;FEMALE;Alive;20.73;NA;397;DiseaseFree;20.73
80;TCGA-A2-A0YC;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N1;stage II;59;FEMALE;Alive;32.52;NA;644;Recurred/Progressed;26.22
81;TCGA-A2-A0YD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T3;N0 ;stage II;63;FEMALE;Alive;25.26;NA;550;DiseaseFree;25.26
82;TCGA-A2-A0YE;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N1;stage II;48;FEMALE;Alive;18.2;NA;253;DiseaseFree;18.2
83;TCGA-A2-A0YF;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;2;3;M0;T1;N0 ;stage I;67;FEMALE;Alive;15.41;NA;289;DiseaseFree;15.41
84;TCGA-A2-A0YG;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;4;4;M0;T2;N3;stage III;63;FEMALE;Alive;21.88;NA;404;DiseaseFree;21.88
85;TCGA-A2-A0YH;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N2;stage III;53;FEMALE;Alive;21.65;NA;379;DiseaseFree;21.65
86;TCGA-A2-A0YI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0 ;stage I;62;FEMALE;Alive;14.49;NA;358;DiseaseFree;14.49
87;TCGA-A2-A0YJ;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;NA;M0;T3;N2;stage III;39;FEMALE;Alive;18.59;NA;326;Recurred/Progressed;18.36
88;TCGA-A2-A0YK;TCGA Breast Carcinoma;Normal-like;Positive;Negative;Negative;1;3;M0;T2;N0 ;stage II;61;FEMALE;Alive;19.32;NA;334;DiseaseFree;19.32
89;TCGA-A2-A0YL;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T3;N2;stage III;48;FEMALE;Alive;14.62;NA;268;DiseaseFree;14.62
90;TCGA-A2-A0YM;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;67;FEMALE;Alive;31.7;NA;662;DiseaseFree;31.7
91;TCGA-A2-A0YT;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;NA;NA;M0;T4;N2;stage III;56;FEMALE;Dead;23.75;723;NA;NA;NA
92;TCGA-A2-A1FV;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T3;N0 ;stage II;74;FEMALE;Alive;23.46;NA;461;DiseaseFree;23.46
93;TCGA-A2-A1FW;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;4;NA;M0;T3;N2;stage III;62;FEMALE;Alive;17.35;NA;221;DiseaseFree;17.35
94;TCGA-A2-A1FX;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T3;N2;stage III;61;FEMALE;Alive;36.76;NA;935;DiseaseFree;36.76
95;TCGA-A2-A1FZ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;63;FEMALE;Alive;22.44;NA;410;DiseaseFree;22.44
96;TCGA-A2-A1G0;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;49;FEMALE;Alive;20.24;NA;380;DiseaseFree;20.24
97;TCGA-A2-A1G1;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;5;NA;M0;T2;N1;stage II;85;FEMALE;Alive;19.19;NA;371;DiseaseFree;19.19
98;TCGA-A2-A1G4;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T3;N1;stage III;71;FEMALE;Alive;19.55;NA;372;DiseaseFree;19.55
99;TCGA-A2-A1G6;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N2;stage III;50;FEMALE;Alive;16.46;NA;132;DiseaseFree;16.46
100;TCGA-A2-A259;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;70;FEMALE;Alive;52.43;NA;1286;DiseaseFree;52.43
101;TCGA-A2-A25A;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;44;FEMALE;Alive;107.62;NA;2968;DiseaseFree;107.62
102;TCGA-A2-A25B;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;39;FEMALE;Alive;16.29;NA;258;DiseaseFree;16.29
103;TCGA-A2-A25C;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;50;FEMALE;Alive;17.18;NA;285;DiseaseFree;17.18
104;TCGA-A2-A25D;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;4;NA;M0;T2;N3;stage III;90;FEMALE;Alive;18.13;NA;243;DiseaseFree;18.13
105;TCGA-A2-A25E;TCGA Breast Carcinoma;NA;Positive;Positive;Equivocal;4;NA;M0;T2;N2;stage III;34;FEMALE;Alive;91.85;NA;2511;DiseaseFree;91.85
106;TCGA-A2-A25F;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;1;NA;M0;T2;N0 ;stage II;66;FEMALE;Alive;10.58;NA;114;DiseaseFree;10.58
107;TCGA-A2-A3KC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;55;FEMALE;Alive;20.86;NA;363;DiseaseFree;20.86
108;TCGA-A2-A3KD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N1;stage III;47;FEMALE;Alive;39.62;NA;804;DiseaseFree;39.62
109;TCGA-A2-A3XS;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N2;stage III;62;FEMALE;Dead;33.9;1032;NA;Recurred/Progressed;22.4
110;TCGA-A2-A3XT;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;45;FEMALE;Alive;82.95;NA;2238;DiseaseFree;82.95
111;TCGA-A2-A3XU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;35;FEMALE;Dead;29.96;912;NA;Recurred/Progressed;21.91
112;TCGA-A2-A3XV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;46;FEMALE;Alive;14.06;NA;428;DiseaseFree;14.06
113;TCGA-A2-A3XW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;42;FEMALE;Alive;49.44;NA;1209;DiseaseFree;49.44
114;TCGA-A2-A3XX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;49;FEMALE;Dead;47.27;NA;1168;NA;NA
115;TCGA-A2-A3XY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;49;FEMALE;Alive;34.95;NA;786;Recurred/Progressed;26.71
116;TCGA-A2-A3XZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;46;FEMALE;Alive;31.96;NA;973;DiseaseFree;31.96
117;TCGA-A2-A3Y0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;57;FEMALE;Alive;38.34;NA;859;DiseaseFree;38.34
118;TCGA-A2-A4RW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;49;FEMALE;Alive;7.29;NA;222;DiseaseFree;7.29
119;TCGA-A2-A4RX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;67;FEMALE;Alive;9;NA;274;DiseaseFree;9
120;TCGA-A2-A4RY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;46;FEMALE;Alive;8.8;NA;268;DiseaseFree;8.8
121;TCGA-A2-A4S0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;77;FEMALE;Alive;8.9;NA;271;DiseaseFree;8.9
122;TCGA-A2-A4S1;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;66;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
123;TCGA-A2-A4S2;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N2;stage III;62;FEMALE;Alive;6.73;NA;205;DiseaseFree;6.73
124;TCGA-A2-A4S3;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;59;FEMALE;Alive;3.42;NA;104;DiseaseFree;3.42
125;TCGA-A7-A0CD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T1;N0;stage I;66;FEMALE;Alive;38.27;NA;171;DiseaseFree;38.27
126;TCGA-A7-A0CE;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;57;FEMALE;Alive;35.28;NA;254;DiseaseFree;35.28
127;TCGA-A7-A0CG;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;1;3;M0;T2;N0 ;stage II;78;FEMALE;Alive;34.26;NA;167;DiseaseFree;34.26
128;TCGA-A7-A0CH;TCGA Breast Carcinoma;Luminal A;Performed but Not Available;Performed but Not Available;Negative;2;3;M0;T2;N0 ;stage II;79;FEMALE;Alive;35.45;NA;162;DiseaseFree;35.45
129;TCGA-A7-A0CJ;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N0 ;stage II;57;FEMALE;Alive;30.58;NA;189;DiseaseFree;30.58
130;TCGA-A7-A0D9;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;2;3;M0;T2;N0 ;stage II;37;FEMALE;Alive;37.42;NA;160;DiseaseFree;37.42
131;TCGA-A7-A0DA;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;62;FEMALE;Alive;35.64;NA;373;DiseaseFree;35.64
132;TCGA-A7-A0DB;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;56;FEMALE;Alive;33.08;NA;141;DiseaseFree;33.08
133;TCGA-A7-A0DC;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;NA;NA;M0;T1;N0 ;stage I;63;FEMALE;Alive;12.68;NA;273;DiseaseFree;12.68
134;TCGA-A7-A13D;TCGA Breast Carcinoma;Basal-like;Negative;Positive;Negative;5;2;M0;T2;N0 ;stage II;46;FEMALE;Alive;31.7;NA;267;DiseaseFree;31.7
135;TCGA-A7-A13E;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;4;NA;MX;T2;N1;stage II;62;FEMALE;Dead;20.17;NA;287;Recurred/Progressed;18.27
136;TCGA-A7-A13F;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T3;N1;stage III;44;FEMALE;Alive;12.71;NA;196;DiseaseFree;12.71
137;TCGA-A7-A13G;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T2;N0;stage II;79;FEMALE;Alive;23.59;NA;208;Recurred/Progressed;19.25
138;TCGA-A7-A13H;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;61;FEMALE;Alive;29.53;NA;551;Recurred/Progressed;26.12
139;TCGA-A7-A26E;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T3;N1;stage III;71;FEMALE;Alive;31.34;NA;421;DiseaseFree;31.34
140;TCGA-A7-A26F;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T1;N0;stage I;55;FEMALE;Alive;24.24;NA;257;DiseaseFree;24.24
141;TCGA-A7-A26G;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;50;FEMALE;Alive;23.72;NA;210;DiseaseFree;23.72
142;TCGA-A7-A26H;TCGA Breast Carcinoma;NA;Positive;Negative;Positive;4;NA;M0;T1;N1;stage II;72;FEMALE;Alive;23.78;NA;65;Recurred/Progressed;10.22
143;TCGA-A7-A26I;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;65;FEMALE;Alive;21.71;NA;122;DiseaseFree;21.71
144;TCGA-A7-A26J;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;49;FEMALE;Alive;20.6;NA;68;DiseaseFree;20.6
145;TCGA-A7-A2KD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N2;stage III;53;FEMALE;Alive;22.31;NA;182;DiseaseFree;22.31
146;TCGA-A7-A3IY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;71;FEMALE;Alive;11.33;NA;151;DiseaseFree;11.33
147;TCGA-A7-A3IZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;62;FEMALE;Alive;10.58;NA;148;DiseaseFree;10.58
148;TCGA-A7-A3J0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;62;FEMALE;Alive;10.28;NA;76;DiseaseFree;10.28
149;TCGA-A7-A3J1;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;63;FEMALE;Alive;11.27;NA;75;DiseaseFree;11.27
150;TCGA-A7-A3RF;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;79;FEMALE;Alive;13.4;NA;54;Recurred/Progressed;6.31
151;TCGA-A7-A425;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N3;stage III;70;FEMALE;Alive;14.68;NA;293;Recurred/Progressed;14.55
152;TCGA-A7-A426;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N3;stage III;50;FEMALE;Alive;11.96;NA;229;DiseaseFree;11.96
153;TCGA-A7-A4SA;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;40;FEMALE;Alive;14.91;NA;241;DiseaseFree;14.91
154;TCGA-A7-A4SB;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N1;stage III;56;FEMALE;Alive;13.73;NA;200;DiseaseFree;13.73
155;TCGA-A7-A4SC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;62;FEMALE;Alive;14.65;NA;215;DiseaseFree;14.65
156;TCGA-A7-A4SD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;52;FEMALE;Alive;14.49;NA;168;DiseaseFree;14.49
157;TCGA-A7-A4SE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;54;FEMALE;Alive;21.16;NA;371;DiseaseFree;21.16
158;TCGA-A7-A4SF;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;54;FEMALE;Alive;17.9;NA;369;DiseaseFree;17.9
159;TCGA-A7-A56D;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;84;FEMALE;Alive;14.72;NA;177;DiseaseFree;14.72
160;TCGA-A7-A5ZV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;62;FEMALE;Alive;12.09;NA;210;DiseaseFree;12.09
161;TCGA-A7-A5ZW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
162;TCGA-A7-A5ZX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
163;TCGA-A7-A6VV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;51;FEMALE;Alive;10.28;NA;181;DiseaseFree;10.28
164;TCGA-A7-A6VW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;48;FEMALE;Alive;9.36;NA;176;DiseaseFree;9.36
165;TCGA-A7-A6VX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;68;FEMALE;Alive;10.41;NA;169;DiseaseFree;10.41
166;TCGA-A7-A6VY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;48;FEMALE;Alive;8.74;NA;125;DiseaseFree;8.74
167;TCGA-A8-A06N;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;4;M0;T4;N0;stage III;66;FEMALE;Alive;0;NA;0;DiseaseFree;0
168;TCGA-A8-A06O;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;60;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
169;TCGA-A8-A06P;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N2;stage III;63;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
170;TCGA-A8-A06Q;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T3;N2;stage III;63;FEMALE;Alive;1.02;NA;31;DiseaseFree;1.02
171;TCGA-A8-A06R;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Equivocal;4;NA;M0;T2;N1;stage II;69;FEMALE;Alive;17.97;NA;547;DiseaseFree;17.97
172;TCGA-A8-A06T;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T3;N1;stage III;75;FEMALE;Alive;41.03;NA;1249;DiseaseFree;41.03
173;TCGA-A8-A06U;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Equivocal;4;NA;M0;T2;N1;stage II;80;FEMALE;Dead;29.01;883;NA;NA;NA
174;TCGA-A8-A06X;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;3;NA;M0;T3;N0;stage II;77;FEMALE;Dead;30.98;943;NA;NA;NA
175;TCGA-A8-A06Y;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N0;stage II;66;FEMALE;Alive;25.99;NA;791;DiseaseFree;25.99
176;TCGA-A8-A06Z;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;5;4;M0;T3;N0;stage II;84;FEMALE;Alive;1.02;NA;31;DiseaseFree;1.02
177;TCGA-A8-A075;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;5;1;M0;T2;N1;stage II;42;FEMALE;Alive;17.02;NA;518;DiseaseFree;17.02
178;TCGA-A8-A076;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;3;1;M0;T2;N0;stage II;66;FEMALE;Alive;53.94;NA;1642;DiseaseFree;53.94
179;TCGA-A8-A079;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T4;N3;stage III;69;FEMALE;Alive;9;NA;274;DiseaseFree;9
180;TCGA-A8-A07B;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;3;NA;M0;T2;N0;stage II;69;FEMALE;Alive;32.98;NA;1004;DiseaseFree;32.98
181;TCGA-A8-A07C;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;57;FEMALE;Alive;19.05;NA;580;DiseaseFree;19.05
182;TCGA-A8-A07E;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;MX;T4;N3;stage X;81;FEMALE;Alive;19.97;NA;608;DiseaseFree;19.97
183;TCGA-A8-A07F;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N1;stage II;65;FEMALE;Alive;18.96;NA;577;DiseaseFree;18.96
184;TCGA-A8-A07G;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N1;stage II;65;FEMALE;Alive;18.96;NA;577;DiseaseFree;18.96
185;TCGA-A8-A07I;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;3;1;M0;T2;N2;stage III;69;FEMALE;Alive;13.99;NA;426;DiseaseFree;13.99
186;TCGA-A8-A07J;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;35;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
187;TCGA-A8-A07L;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T3;N1;stage III;58;FEMALE;Alive;17.02;NA;518;DiseaseFree;17.02
188;TCGA-A8-A07O;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;51;FEMALE;Alive;9.99;NA;304;DiseaseFree;9.99
189;TCGA-A8-A07P;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;3;3;M0;T2;N1;stage II;68;FEMALE;Alive;10.97;NA;334;DiseaseFree;10.97
190;TCGA-A8-A07R;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Equivocal;5;2;M0;T2;N3;stage III;80;FEMALE;Alive;8.97;NA;273;DiseaseFree;8.97
191;TCGA-A8-A07S;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;2;NA;M0;T2;N0;stage II;73;FEMALE;Alive;7.98;NA;243;DiseaseFree;7.98
192;TCGA-A8-A07U;TCGA Breast Carcinoma;Basal-like;Negative;Positive;Negative;5;NA;M0;T2;N2;stage III;66;FEMALE;Alive;9.95;NA;303;DiseaseFree;9.95
193;TCGA-A8-A07W;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M1;T2;NX;stage IV;76;FEMALE;Alive;9.99;NA;304;DiseaseFree;9.99
194;TCGA-A8-A07Z;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N0;stage II;85;FEMALE;Alive;28.02;NA;853;DiseaseFree;28.02
195;TCGA-A8-A081;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;4;1;M0;T2;N0;stage II;80;FEMALE;Alive;0;NA;0;DiseaseFree;0
196;TCGA-A8-A082;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;58;FEMALE;Alive;18.04;NA;549;DiseaseFree;18.04
197;TCGA-A8-A083;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T3;N0;stage II;67;FEMALE;Alive;0;NA;0;DiseaseFree;0
198;TCGA-A8-A084;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;2;M0;T2;N1;stage II;81;FEMALE;Alive;15.05;NA;458;DiseaseFree;15.05
199;TCGA-A8-A085;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;44;MALE;Alive;36.93;NA;1124;DiseaseFree;36.93
200;TCGA-A8-A086;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N1;stage II;59;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
201;TCGA-A8-A08A;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0;stage I;89;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
202;TCGA-A8-A08B;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;1;NA;M0;T2;N0;stage II;52;FEMALE;Alive;23.06;NA;702;DiseaseFree;23.06
203;TCGA-A8-A08C;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;65;FEMALE;Alive;19.97;NA;608;DiseaseFree;19.97
204;TCGA-A8-A08F;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T2;N3;stage III;59;FEMALE;Alive;18.04;NA;549;DiseaseFree;18.04
205;TCGA-A8-A08G;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;2;4;M0;T2;N0;stage II;41;FEMALE;Alive;19.94;NA;607;DiseaseFree;19.94
206;TCGA-A8-A08H;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Positive;1;3;M0;T2;N0;stage II;66;FEMALE;Alive;0;NA;0;DiseaseFree;0
207;TCGA-A8-A08I;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;53;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
208;TCGA-A8-A08J;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Negative;4;1;M1;T4;N3;stage IV;52;FEMALE;Dead;37.02;1127;NA;NA;NA
209;TCGA-A8-A08L;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Negative;4;1;M0;T3;N2;stage III;89;FEMALE;Dead;9.99;304;NA;NA;NA
210;TCGA-A8-A08O;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M1;T2;N3;stage IV;45;FEMALE;Alive;30.98;NA;943;DiseaseFree;30.98
211;TCGA-A8-A08P;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;4;NA;M0;T2;N2;stage III;70;FEMALE;Alive;30.98;NA;943;DiseaseFree;30.98
212;TCGA-A8-A08R;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N1;stage II;52;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
213;TCGA-A8-A08S;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;NA;NA;M0;T1;N1;stage II;71;FEMALE;Alive;19.05;NA;580;DiseaseFree;19.05
214;TCGA-A8-A08T;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M1;T2;N1;stage IV;64;FEMALE;Alive;92.97;NA;2830;DiseaseFree;92.97
215;TCGA-A8-A08X;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T4d;N3;stage III;43;FEMALE;Alive;33.97;NA;1034;DiseaseFree;33.97
216;TCGA-A8-A08Z;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T4;N3;stage III;76;FEMALE;Alive;39.98;NA;1217;DiseaseFree;39.98
217;TCGA-A8-A090;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;74;FEMALE;Alive;0;NA;0;DiseaseFree;0
218;TCGA-A8-A091;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;4;3;M0;T2;N0;stage II;61;FEMALE;Alive;19.05;NA;580;DiseaseFree;19.05
219;TCGA-A8-A092;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;2;NA;M0;T2;N2;stage III;48;FEMALE;Alive;16;NA;487;DiseaseFree;16
220;TCGA-A8-A093;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;61;FEMALE;Alive;17.94;NA;546;DiseaseFree;17.94
221;TCGA-A8-A094;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Negative;1;1;M0;T2;N0;stage II;75;FEMALE;Alive;0;NA;0;DiseaseFree;0
222;TCGA-A8-A095;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;45;FEMALE;Alive;41.95;NA;1277;DiseaseFree;41.95
223;TCGA-A8-A096;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;73;FEMALE;Alive;0;NA;0;DiseaseFree;0
224;TCGA-A8-A097;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;2;NA;M0;T2;N1;stage II;65;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
225;TCGA-A8-A099;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;3;3;MX;T4;N3;stage X;76;FEMALE;Alive;9.99;NA;304;DiseaseFree;9.99
226;TCGA-A8-A09A;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;NX;stage X;40;FEMALE;Alive;9.99;NA;304;DiseaseFree;9.99
227;TCGA-A8-A09B;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T4;N1;stage III;58;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
228;TCGA-A8-A09C;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;MX;T2;N0;stage X;69;FEMALE;Alive;1.02;NA;31;DiseaseFree;1.02
229;TCGA-A8-A09D;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;47;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
230;TCGA-A8-A09E;TCGA Breast Carcinoma;NA;Positive;Positive;Equivocal;NA;NA;M0;T4;N1;stage III;73;FEMALE;Alive;30.98;NA;943;DiseaseFree;30.98
231;TCGA-A8-A09G;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;1;1;M0;T3;N3;stage III;79;FEMALE;Alive;0;NA;0;DiseaseFree;0
232;TCGA-A8-A09I;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;4;M0;T2;N0;stage II;84;FEMALE;Alive;33.05;NA;1006;DiseaseFree;33.05
233;TCGA-A8-A09K;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;NA;NA;M0;T1;N1;stage II;68;FEMALE;Alive;29.96;NA;912;DiseaseFree;29.96
234;TCGA-A8-A09M;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N3;stage III;75;FEMALE;Alive;15.01;NA;457;DiseaseFree;15.01
235;TCGA-A8-A09N;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;4;NA;M0;T2;N3;stage III;57;FEMALE;Alive;1.02;NA;31;DiseaseFree;1.02
236;TCGA-A8-A09Q;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;NA;M0;T4;N2;stage III;83;FEMALE;Alive;25;NA;761;DiseaseFree;25
237;TCGA-A8-A09R;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;82;FEMALE;Alive;8.97;NA;273;DiseaseFree;8.97
238;TCGA-A8-A09T;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;MX;T1;N0;stage X;68;FEMALE;Alive;19.02;NA;579;DiseaseFree;19.02
239;TCGA-A8-A09V;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;51;FEMALE;Alive;15.01;NA;457;DiseaseFree;15.01
240;TCGA-A8-A09W;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N3;stage III;70;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
241;TCGA-A8-A09X;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Negative;4;1;M0;T2;N3;stage III;62;FEMALE;Dead;13.99;426;NA;NA;NA
242;TCGA-A8-A09Z;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;NA;M0;T3;N0;stage II;83;FEMALE;Alive;0;NA;0;DiseaseFree;0
243;TCGA-A8-A0A1;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;84;FEMALE;Alive;11.99;NA;365;DiseaseFree;11.99
244;TCGA-A8-A0A2;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;66;FEMALE;Alive;19.02;NA;579;DiseaseFree;19.02
245;TCGA-A8-A0A4;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N0;stage II;73;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
246;TCGA-A8-A0A6;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N3;stage III;64;FEMALE;Alive;21.02;NA;640;DiseaseFree;21.02
247;TCGA-A8-A0A7;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T2;N1;stage II;57;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
248;TCGA-A8-A0A9;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;80;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
249;TCGA-A8-A0AB;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;54;FEMALE;Alive;17.02;NA;518;DiseaseFree;17.02
250;TCGA-A8-A0AD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;83;FEMALE;Alive;38.01;NA;1157;DiseaseFree;38.01
251;TCGA-AC-A23C;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;MX;T2;N1;stage II;62;FEMALE;Alive;0.95;NA;29;DiseaseFree;0.95
252;TCGA-AC-A23E;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T2;N1;stage II;50;FEMALE;Alive;2.37;NA;72;DiseaseFree;2.37
253;TCGA-AC-A23G;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage II;76;FEMALE;Alive;10.84;NA;330;DiseaseFree;10.84
254;TCGA-AC-A23H;TCGA Breast Carcinoma;NA;Positive;Negative;Positive;3;NA;M0;T2;NX;stage II;90;FEMALE;Dead;5.72;NA;81;NA;NA
255;TCGA-AC-A2B8;TCGA Breast Carcinoma;NA;NA;NA;NA;1;NA;M0;T3;N0 ;stage II;84;FEMALE;Alive;1.48;NA;45;DiseaseFree;1.48
256;TCGA-AC-A2BK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N2;stage III;78;FEMALE;Alive;38.5;NA;1172;DiseaseFree;38.5
257;TCGA-AC-A2BM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;41;FEMALE;Alive;38.17;NA;1162;DiseaseFree;38.17
258;TCGA-AC-A2FB;TCGA Breast Carcinoma;NA;NA;NA;NA;1;NA;MX;T2;N0;stage II;65;FEMALE;Alive;40.54;NA;44;DiseaseFree;40.54
259;TCGA-AC-A2FE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
260;TCGA-AC-A2FF;TCGA Breast Carcinoma;NA;NA;NA;NA;1;NA;MX;T2;N1;stage II;40;FEMALE;Alive;55.39;NA;1686;DiseaseFree;55.39
261;TCGA-AC-A2FG;TCGA Breast Carcinoma;NA;NA;NA;NA;1;NA;MX;T2;N1;stage II;79;FEMALE;Alive;36.96;NA;1125;DiseaseFree;36.96
262;TCGA-AC-A2FK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;45;FEMALE;Alive;38.76;NA;1180;DiseaseFree;38.76
263;TCGA-AC-A2FM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;87;FEMALE;Dead;26.02;792;NA;NA;NA
264;TCGA-AC-A2FO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;65;FEMALE;Alive;50.66;NA;1542;DiseaseFree;50.66
265;TCGA-AC-A2QH;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;58;FEMALE;Alive;1.02;NA;31;DiseaseFree;1.02
266;TCGA-AC-A2QI;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N1;stage III;76;FEMALE;Alive;0.92;NA;28;DiseaseFree;0.92
267;TCGA-AC-A2QJ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T4;N0;stage III;48;FEMALE;Alive;2.27;NA;69;DiseaseFree;2.27
268;TCGA-AC-A3BB;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N2;stage III;46;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
269;TCGA-AC-A3EH;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
270;TCGA-AC-A3HN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;87;FEMALE;Alive;0.69;NA;21;DiseaseFree;0.69
271;TCGA-AC-A3OD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;68;FEMALE;Alive;14.82;NA;35;DiseaseFree;14.82
272;TCGA-AC-A3QP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;79;FEMALE;Alive;9.4;NA;286;DiseaseFree;9.4
273;TCGA-AC-A3QQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
274;TCGA-AC-A3TM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
275;TCGA-AC-A3TN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;75;FEMALE;Alive;1.12;NA;34;DiseaseFree;1.12
276;TCGA-AC-A3W5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;65;FEMALE;Alive;1.81;NA;55;DiseaseFree;1.81
277;TCGA-AC-A3W6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N1;stage III;90;FEMALE;Alive;1.68;NA;51;DiseaseFree;1.68
278;TCGA-AC-A3W7;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
279;TCGA-AC-A3YI;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N3;stage III;74;FEMALE;Alive;1.54;NA;47;DiseaseFree;1.54
280;TCGA-AC-A3YJ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0 ;stage II;66;FEMALE;Alive;1.31;NA;40;DiseaseFree;1.31
281;TCGA-AC-A4ZE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
282;TCGA-AC-A5EH;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
283;TCGA-AC-A5EI;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
284;TCGA-AC-A5XS;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;74;FEMALE;Alive;1.54;NA;47;DiseaseFree;1.54
285;TCGA-AC-A5XU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
286;TCGA-AC-A62V;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
287;TCGA-AC-A62X;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;72;FEMALE;Alive;1.12;NA;34;DiseaseFree;1.12
288;TCGA-AC-A62Y;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;79;FEMALE;Alive;1.81;NA;55;DiseaseFree;1.81
289;TCGA-AC-A6IV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;47;FEMALE;Alive;1.18;NA;36;DiseaseFree;1.18
290;TCGA-AC-A6IW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
291;TCGA-AC-A6IX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
292;TCGA-AC-A6IX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
293;TCGA-AC-A6NO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
294;TCGA-AC-A7VB;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
295;TCGA-AC-A7VC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
296;TCGA-AC-A8OP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
297;TCGA-AC-A8OQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
298;TCGA-AC-A8OR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
299;TCGA-AC-A8OS;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
300;TCGA-AN-A03X;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;74;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
301;TCGA-AN-A03Y;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;66;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
302;TCGA-AN-A041;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Equivocal;4;4;M0;T2;N1;stage II;29;FEMALE;Alive;0.23;NA;7;DiseaseFree;0.23
303;TCGA-AN-A046;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;68;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
304;TCGA-AN-A049;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N0;stage II;62;FEMALE;Alive;0.62;NA;19;DiseaseFree;0.62
305;TCGA-AN-A04A;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N2;stage III;36;FEMALE;Alive;2.96;NA;90;DiseaseFree;2.96
306;TCGA-AN-A04C;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;NA;M0;T2;N1;stage II;51;FEMALE;Alive;1.77;NA;54;DiseaseFree;1.77
307;TCGA-AN-A04D;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;58;FEMALE;Alive;1.71;NA;52;DiseaseFree;1.71
308;TCGA-AN-A0AJ;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;4;M0;T3;N0;stage II;79;FEMALE;Alive;8.02;NA;244;DiseaseFree;8.02
309;TCGA-AN-A0AK;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;NA;M0;T2;N0;stage II;76;FEMALE;Alive;7.36;NA;224;DiseaseFree;7.36
310;TCGA-AN-A0AL;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T4;N0;stage III;41;FEMALE;Alive;6.5;NA;198;DiseaseFree;6.5
311;TCGA-AN-A0AM;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;4;M0;T2;N0;stage II;56;FEMALE;Alive;0.16;NA;5;DiseaseFree;0.16
312;TCGA-AN-A0AR;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;55;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
313;TCGA-AN-A0AS;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;2;4;M0;T2;N2;stage III;70;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
314;TCGA-AN-A0AT;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;62;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
315;TCGA-AN-A0FD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;2;3;M0;T2;N0;stage II;71;FEMALE;Alive;6.44;NA;196;DiseaseFree;6.44
316;TCGA-AN-A0FF;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T1;N0;stage I;32;FEMALE;Alive;4.63;NA;141;DiseaseFree;4.63
317;TCGA-AN-A0FJ;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;2;M1;T2;N2;stage IV;59;FEMALE;Alive;7.95;NA;242;DiseaseFree;7.95
318;TCGA-AN-A0FK;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T4;N0;stage III;88;FEMALE;Alive;7;NA;213;DiseaseFree;7
319;TCGA-AN-A0FL;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;62;FEMALE;Alive;7.59;NA;231;DiseaseFree;7.59
320;TCGA-AN-A0FN;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;61;FEMALE;Alive;7.16;NA;218;DiseaseFree;7.16
321;TCGA-AN-A0FS;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;2;3;M0;T1;N0;stage I;55;FEMALE;Alive;6.27;NA;191;DiseaseFree;6.27
322;TCGA-AN-A0FT;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;3;3;M0;T2;N1;stage II;63;FEMALE;Alive;6.01;NA;183;DiseaseFree;6.01
323;TCGA-AN-A0FV;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;2;1;M0;T2;N0;stage II;58;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
324;TCGA-AN-A0FW;TCGA Breast Carcinoma;Luminal A;Positive;Indeterminate;Negative;3;3;M0;T2;N2;stage III;67;FEMALE;Alive;0.36;NA;11;DiseaseFree;0.36
325;TCGA-AN-A0FX;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;4;2;M0;T2;N0;stage II;52;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
326;TCGA-AN-A0FY;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T1;N0;stage I;55;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
327;TCGA-AN-A0FZ;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Equivocal;2;3;M0;T2;N2;stage III;45;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
328;TCGA-AN-A0G0;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;56;FEMALE;Alive;0.53;NA;16;DiseaseFree;0.53
329;TCGA-AN-A0XL;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;61;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
330;TCGA-AN-A0XN;TCGA Breast Carcinoma;Luminal A;Negative;Positive;Negative;3;3;M0;T2;N2;stage III;68;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
331;TCGA-AN-A0XO;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;4;3;M0;T2;N2;stage III;59;FEMALE;Alive;12.32;NA;375;DiseaseFree;12.32
332;TCGA-AN-A0XP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N2;stage III;69;FEMALE;Alive;0.3;NA;9;DiseaseFree;0.3
333;TCGA-AN-A0XR;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;NA;M0;T2;N2;stage III;55;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
334;TCGA-AN-A0XS;TCGA Breast Carcinoma;Luminal A;Negative;Positive;Negative;2;3;M0;T2;N2;stage III;63;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
335;TCGA-AN-A0XT;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;5;3;M0;T2;N2;stage III;54;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
336;TCGA-AN-A0XU;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;54;FEMALE;Alive;0.33;NA;10;DiseaseFree;0.33
337;TCGA-AN-A0XV;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N2;stage III;67;FEMALE;Alive;5.32;NA;162;DiseaseFree;5.32
338;TCGA-AN-A0XW;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N2;stage III;36;FEMALE;Alive;5.58;NA;170;DiseaseFree;5.58
339;TCGA-AO-A03L;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;4;1;M0;T3;N2;stage III;34;FEMALE;Alive;80.22;NA;2442;DiseaseFree;80.22
340;TCGA-AO-A03M;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;29;FEMALE;Alive;47.8;NA;1455;DiseaseFree;47.8
341;TCGA-AO-A03N;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Negative;2;4;M0;T2;N1;stage II;59;FEMALE;Alive;66.72;NA;1645;Recurred/Progressed;54.04
342;TCGA-AO-A03O;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N0 ;stage II;69;FEMALE;Dead;81.57;2483;NA;NA;NA
343;TCGA-AO-A03P;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;54;FEMALE;Dead;95.63;NA;2576;Recurred/Progressed;63.14
344;TCGA-AO-A03R;TCGA Breast Carcinoma;Normal-like;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;57;FEMALE;Alive;68.69;NA;1707;DiseaseFree;68.69
345;TCGA-AO-A03T;TCGA Breast Carcinoma;Normal-like;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;42;FEMALE;Alive;47.83;NA;1187;DiseaseFree;47.83
346;TCGA-AO-A03U;TCGA Breast Carcinoma;Normal-like;Negative;Negative;Negative;5;2;M0;T1;N0 ;stage I;31;FEMALE;Dead;59;1796;NA;Recurred/Progressed;53.02
347;TCGA-AO-A03V;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0 ;stage I;41;FEMALE;Alive;29.11;NA;886;DiseaseFree;29.11
348;TCGA-AO-A0J2;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Negative;5;2;M0;T1;N0 ;stage I;41;FEMALE;Alive;32.75;NA;585;DiseaseFree;32.75
349;TCGA-AO-A0J3;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N1;stage II;67;FEMALE;Alive;21.39;NA;302;DiseaseFree;21.39
350;TCGA-AO-A0J4;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T1;N0 ;stage I;41;FEMALE;Alive;17.64;NA;294;DiseaseFree;17.64
351;TCGA-AO-A0J5;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;NA;NA;M1;T4;N1;stage IV;48;FEMALE;Dead;26.02;NA;735;NA;NA
352;TCGA-AO-A0J6;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;61;FEMALE;Alive;37.45;NA;775;DiseaseFree;37.45
353;TCGA-AO-A0J7;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;71;FEMALE;Alive;20.3;NA;261;DiseaseFree;20.3
354;TCGA-AO-A0J8;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;61;FEMALE;Alive;22.34;NA;277;DiseaseFree;22.34
355;TCGA-AO-A0J9;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N3;stage III;61;FEMALE;Alive;52.99;NA;1256;Recurred/Progressed;35.02
356;TCGA-AO-A0JA;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N3;stage III;36;FEMALE;Alive;21.52;NA;346;Recurred/Progressed;4.7
357;TCGA-AO-A0JB;TCGA Breast Carcinoma;Normal-like;Positive;Positive;Negative;5;2;M0;T3;N1;stage III;50;FEMALE;Alive;50.66;NA;1150;DiseaseFree;50.66
358;TCGA-AO-A0JC;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;5;2;M0;T2;N0 ;stage II;64;FEMALE;Alive;50.82;NA;1547;DiseaseFree;50.82
359;TCGA-AO-A0JD;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T3;N1;stage III;59;FEMALE;Alive;71.94;NA;1813;DiseaseFree;71.94
360;TCGA-AO-A0JE;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;1;M0;T2;N2;stage III;53;FEMALE;Alive;76.71;NA;1966;DiseaseFree;76.71
361;TCGA-AO-A0JF;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N1;stage II;68;FEMALE;Alive;21.35;NA;354;DiseaseFree;21.35
362;TCGA-AO-A0JG;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N2;stage III;49;FEMALE;Alive;26.22;NA;449;DiseaseFree;26.22
363;TCGA-AO-A0JI;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;4;M0;T1;N1;stage II;56;FEMALE;Alive;38.5;NA;1172;DiseaseFree;38.5
364;TCGA-AO-A0JJ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N1;stage II;54;FEMALE;Alive;61.99;NA;1512;DiseaseFree;61.99
365;TCGA-AO-A0JL;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N2;stage III;59;FEMALE;Alive;55.29;NA;1319;DiseaseFree;55.29
366;TCGA-AO-A0JM;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;4;M0;T2;N1;stage II;40;FEMALE;Alive;71.75;NA;1826;DiseaseFree;71.75
367;TCGA-AO-A124;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;38;FEMALE;Alive;102.5;NA;3120;DiseaseFree;102.5
368;TCGA-AO-A125;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;72;FEMALE;Alive;99.18;NA;3019;DiseaseFree;99.18
369;TCGA-AO-A126;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N0 ;stage II;39;FEMALE;Alive;93.63;NA;2850;Recurred/Progressed;8.77
370;TCGA-AO-A128;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;61;FEMALE;Alive;94.51;NA;2877;DiseaseFree;94.51
371;TCGA-AO-A129;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;29;FEMALE;Alive;96.02;NA;2923;DiseaseFree;96.02
372;TCGA-AO-A12A;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;47;FEMALE;Alive;90.51;NA;2755;DiseaseFree;90.51
373;TCGA-AO-A12B;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N0 ;stage II;63;FEMALE;Alive;77.5;NA;2359;DiseaseFree;77.5
374;TCGA-AO-A12C;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;4;NA;M0;T2;N1;stage II;42;FEMALE;Alive;65.51;NA;1994;DiseaseFree;65.51
375;TCGA-AO-A12D;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;5;1;M0;T1;N1;stage II;43;FEMALE;Alive;63.99;NA;1948;DiseaseFree;63.99
376;TCGA-AO-A12E;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T3;N0 ;stage II;51;FEMALE;Alive;57.26;NA;1743;DiseaseFree;57.26
377;TCGA-AO-A12F;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;36;FEMALE;Alive;48.32;NA;1471;DiseaseFree;48.32
378;TCGA-AO-A12G;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N0 ;stage II;75;FEMALE;Alive;41.59;NA;1266;DiseaseFree;41.59
379;TCGA-AO-A12H;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;69;FEMALE;Alive;28.35;NA;863;DiseaseFree;28.35
380;TCGA-AO-A1KO;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T3;N0 ;stage II;46;FEMALE;Alive;14.72;NA;448;DiseaseFree;14.72
381;TCGA-AO-A1KP;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N1;stage II;77;FEMALE;Alive;82.56;NA;2513;DiseaseFree;82.56
382;TCGA-AO-A1KQ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T4;N1;stage III;84;MALE;Alive;61.83;NA;1519;DiseaseFree;61.83
383;TCGA-AO-A1KR;TCGA Breast Carcinoma;NA;Negative;Negative;NA;5;NA;M0;T2;N0;stage II;51;FEMALE;Alive;70.34;NA;2141;DiseaseFree;70.34
384;TCGA-AO-A1KS;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;69;FEMALE;Alive;0.53;NA;16;DiseaseFree;0.53
385;TCGA-AO-A1KT;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T1;N1;stage II;78;FEMALE;Alive;17.77;NA;541;DiseaseFree;17.77
386;TCGA-AQ-A04H;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;NA;MX;T2;N2;stage III;61;FEMALE;Alive;24.77;NA;439;DiseaseFree;24.77
387;TCGA-AQ-A04J;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;45;FEMALE;Alive;26.91;NA;160;DiseaseFree;26.91
388;TCGA-AQ-A04L;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Positive;3;2;MX;T2;N0 ;stage II;48;FEMALE;Alive;129.99;NA;3359;DiseaseFree;129.99
389;TCGA-AQ-A0Y5;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;MX;T2;N2;stage III;70;FEMALE;Dead;5.65;172;NA;NA;NA
390;TCGA-AQ-A1H2;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;2;NA;MX;T2;N2;stage III;84;FEMALE;Alive;15.6;NA;230;DiseaseFree;15.6
391;TCGA-AQ-A1H3;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T2;N3;stage III;49;FEMALE;Alive;13.21;NA;162;DiseaseFree;13.21
392;TCGA-AQ-A54N;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;51;FEMALE;Alive;2.56;NA;78;DiseaseFree;2.56
393;TCGA-AQ-A54O;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;51;MALE;Alive;21.85;NA;665;DiseaseFree;21.85
394;TCGA-AQ-A7U7;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N2;stage III;55;FEMALE;Alive;9.99;NA;304;DiseaseFree;9.99
395;TCGA-AR-A0TP;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;2;M0;T2;N0;stage II;43;FEMALE;Alive;82.82;NA;2521;DiseaseFree;82.82
396;TCGA-AR-A0TQ;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;4;4;M0;T3;N1;stage III;27;FEMALE;Alive;49.28;NA;1500;DiseaseFree;49.28
397;TCGA-AR-A0TR;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;68;FEMALE;Dead;5.26;160;NA;NA;NA
398;TCGA-AR-A0TS;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;46;FEMALE;Alive;37.39;NA;1138;DiseaseFree;37.39
399;TCGA-AR-A0TT;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;1;4;M0;T2;N2;stage III;53;FEMALE;Alive;56.83;NA;1730;DiseaseFree;56.83
400;TCGA-AR-A0TU;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;35;FEMALE;Alive;11.83;NA;360;DiseaseFree;11.83
401;TCGA-AR-A0TV;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N0;stage II;66;FEMALE;Alive;29.73;NA;905;DiseaseFree;29.73
402;TCGA-AR-A0TW;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T3;N1;stage III;50;FEMALE;Alive;24.28;NA;739;DiseaseFree;24.28
403;TCGA-AR-A0TX;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;1;1;M0;T1;N1;stage II;64;FEMALE;Alive;64.78;NA;1972;DiseaseFree;64.78
404;TCGA-AR-A0TY;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;4;M0;T2;N0;stage II;54;FEMALE;Dead;55.81;1699;NA;NA;NA
405;TCGA-AR-A0TZ;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N2;stage III;43;FEMALE;Alive;76.08;NA;2316;DiseaseFree;76.08
406;TCGA-AR-A0U0;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;1;NA;M0;T2;N1;stage II;73;FEMALE;Alive;65.31;NA;1988;DiseaseFree;65.31
407;TCGA-AR-A0U1;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;36;FEMALE;Alive;70.11;NA;2134;DiseaseFree;70.11
408;TCGA-AR-A0U2;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T2;N2;stage III;47;FEMALE;Dead;83.8;2551;NA;NA;NA
409;TCGA-AR-A0U3;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N1;stage II;59;FEMALE;Alive;76.12;NA;2317;DiseaseFree;76.12
410;TCGA-AR-A0U4;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;54;FEMALE;Alive;55.32;NA;1684;DiseaseFree;55.32
411;TCGA-AR-A1AH;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;2;M0;T2;N1;stage II;51;FEMALE;Alive;75.49;NA;2298;Recurred/Progressed;37.32
412;TCGA-AR-A1AI;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;47;FEMALE;Alive;61.79;NA;1881;Recurred/Progressed;19.32
413;TCGA-AR-A1AJ;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;2;M0;T1;N0;stage I;83;FEMALE;Alive;52.73;NA;1605;DiseaseFree;52.73
414;TCGA-AR-A1AK;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;70;FEMALE;Alive;51.22;NA;1559;DiseaseFree;51.22
415;TCGA-AR-A1AL;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T3;N1;stage III;60;FEMALE;Alive;48.78;NA;1485;DiseaseFree;48.78
416;TCGA-AR-A1AM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N1;stage II;52;FEMALE;Alive;62.52;NA;1903;DiseaseFree;62.52
417;TCGA-AR-A1AN;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;5;NA;M0;T2;N0;stage II;46;FEMALE;Alive;43.69;NA;1330;DiseaseFree;43.69
418;TCGA-AR-A1AO;TCGA Breast Carcinoma;Normal-like;Positive;Negative;Negative;5;2;M0;T1;N1;stage II;47;FEMALE;Alive;43.53;NA;1325;DiseaseFree;43.53
419;TCGA-AR-A1AP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0;stage I;80;FEMALE;Alive;39.95;NA;1216;DiseaseFree;39.95
420;TCGA-AR-A1AQ;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;49;FEMALE;Alive;43.04;NA;1310;DiseaseFree;43.04
421;TCGA-AR-A1AR;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T1;N2;stage III;50;FEMALE;Dead;17.21;524;NA;Recurred/Progressed;12.71
422;TCGA-AR-A1AS;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;54;FEMALE;Alive;40.8;NA;1242;DiseaseFree;40.8
423;TCGA-AR-A1AT;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;1;NA;M0;T2;N0;stage II;62;FEMALE;Dead;41.79;1272;NA;NA;NA
424;TCGA-AR-A1AU;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N2;stage III;39;FEMALE;Alive;46.29;NA;1409;DiseaseFree;46.29
425;TCGA-AR-A1AV;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N1;stage II;68;MALE;Alive;42.54;NA;1295;DiseaseFree;42.54
426;TCGA-AR-A1AW;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0;stage II;65;FEMALE;Alive;35.22;NA;1072;DiseaseFree;35.22
427;TCGA-AR-A1AX;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;5;3;M0;T1;N0;stage I;64;FEMALE;Alive;36.24;NA;1103;DiseaseFree;36.24
428;TCGA-AR-A1AY;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0;stage I;65;FEMALE;Alive;20.2;NA;615;DiseaseFree;20.2
429;TCGA-AR-A24H;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;65;FEMALE;Alive;109.49;NA;3333;DiseaseFree;109.49
430;TCGA-AR-A24K;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;46;FEMALE;Alive;50.85;NA;1548;DiseaseFree;50.85
431;TCGA-AR-A24L;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;26;FEMALE;Alive;72.96;NA;2221;DiseaseFree;72.96
432;TCGA-AR-A24M;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N2;stage III;38;FEMALE;Alive;65.41;NA;1991;DiseaseFree;65.41
433;TCGA-AR-A24N;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T1;N0;stage I;54;FEMALE;Alive;68.13;NA;2074;DiseaseFree;68.13
434;TCGA-AR-A24O;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T3;N2;stage III;43;FEMALE;Alive;65.64;NA;1998;DiseaseFree;65.64
435;TCGA-AR-A24P;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;47;FEMALE;Alive;0.85;NA;26;DiseaseFree;0.85
436;TCGA-AR-A24Q;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;5;NA;M0;T3;N0;stage II;49;FEMALE;Alive;66;NA;2009;DiseaseFree;66
437;TCGA-AR-A24R;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T1;N2;stage III;45;FEMALE;Alive;57.36;NA;1746;DiseaseFree;57.36
438;TCGA-AR-A24S;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;61;FEMALE;Alive;62.02;NA;1888;DiseaseFree;62.02
439;TCGA-AR-A24T;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T3;N3;stage III;46;FEMALE;Alive;53.22;NA;1620;DiseaseFree;53.22
440;TCGA-AR-A24U;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;1;NA;M0;T1;N1;stage II;47;FEMALE;Alive;53.32;NA;1623;DiseaseFree;53.32
441;TCGA-AR-A24V;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;52;FEMALE;Alive;54.14;NA;1648;DiseaseFree;54.14
442;TCGA-AR-A24W;TCGA Breast Carcinoma;NA;NA;NA;NA;1;NA;M0;T2;N1;stage II;55;FEMALE;Alive;50.92;NA;1550;DiseaseFree;50.92
443;TCGA-AR-A24X;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;52;FEMALE;Alive;48.13;NA;1465;DiseaseFree;48.13
444;TCGA-AR-A24Z;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;57;FEMALE;Alive;51.71;NA;1574;DiseaseFree;51.71
445;TCGA-AR-A250;TCGA Breast Carcinoma;NA;Positive;Negative;Positive;3;NA;M0;T2;N0;stage II;58;FEMALE;Alive;56.11;NA;1708;DiseaseFree;56.11
446;TCGA-AR-A251;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;5;NA;M0;T2;N2;stage III;51;FEMALE;Alive;45.14;NA;1374;DiseaseFree;45.14
447;TCGA-AR-A252;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;50;FEMALE;Alive;40.6;NA;1236;DiseaseFree;40.6
448;TCGA-AR-A254;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;M0;T2;N2;stage III;50;FEMALE;Alive;39.82;NA;1212;DiseaseFree;39.82
449;TCGA-AR-A255;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;M0;T1;N0;stage I;62;FEMALE;Alive;34.79;NA;1059;DiseaseFree;34.79
450;TCGA-AR-A256;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;45;FEMALE;Dead;93.76;2854;NA;NA;NA
451;TCGA-AR-A2LE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;69;FEMALE;Alive;128.55;NA;3913;DiseaseFree;128.55
452;TCGA-AR-A2LH;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;55;FEMALE;Dead;20.24;616;NA;NA;NA
453;TCGA-AR-A2LJ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
454;TCGA-AR-A2LK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N2;stage III;62;FEMALE;Alive;42.84;NA;1304;DiseaseFree;42.84
455;TCGA-AR-A2LL;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0;stage II;70;FEMALE;Alive;7.36;NA;224;DiseaseFree;7.36
456;TCGA-AR-A2LM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N1;stage II;49;FEMALE;Alive;40.01;NA;1218;DiseaseFree;40.01
457;TCGA-AR-A2LN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;65;FEMALE;Alive;17.08;NA;520;DiseaseFree;17.08
458;TCGA-AR-A2LO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;46;FEMALE;Alive;20.8;NA;633;DiseaseFree;20.8
459;TCGA-AR-A2LQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0;stage II;59;FEMALE;Alive;16.95;NA;516;DiseaseFree;16.95
460;TCGA-AR-A2LR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;49;FEMALE;Alive;20.37;NA;620;DiseaseFree;20.37
461;TCGA-AR-A5QM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;62;FEMALE;Alive;54.7;NA;1440;Recurred/Progressed;31.8
462;TCGA-AR-A5QN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;68;FEMALE;Alive;16.03;NA;396;DiseaseFree;16.03
463;TCGA-AR-A5QP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;54;FEMALE;Alive;20.43;NA;439;DiseaseFree;20.43
464;TCGA-AR-A5QQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N1;stage III;68;FEMALE;Dead;10.58;322;NA;Recurred/Progressed;9.89
465;TCGA-B6-A0I1;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;73;FEMALE;Dead;77.56;2361;NA;NA;NA
466;TCGA-B6-A0I2;TCGA Breast Carcinoma;Basal-like;Performed but Not Available;Performed but Not Available;Negative;5;2;M0;T1;N0 ;stage I;45;FEMALE;Alive;143.27;NA;3827;DiseaseFree;143.27
467;TCGA-B6-A0I5;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;49;FEMALE;Alive;149.47;NA;4550;DiseaseFree;149.47
468;TCGA-B6-A0I6;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Not Available;5;NA;M0;T1;N1;stage II;49;FEMALE;Dead;32.75;991;NA;Recurred/Progressed;28.22
469;TCGA-B6-A0I8;TCGA Breast Carcinoma;Luminal A;Not Performed;Not Performed;Not Available;2;NA;M0;T1;NX;stage X;46;FEMALE;Dead;24.61;749;NA;Recurred/Progressed;24.51
470;TCGA-B6-A0I9;TCGA Breast Carcinoma;HER2-enriched;Indeterminate;Positive;Positive;4;1;M1;T3;NX;stage IV;62;FEMALE;Dead;12.12;369;NA;NA;NA
471;TCGA-B6-A0IA;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0 ;stage II;51;FEMALE;Alive;220.73;NA;6719;DiseaseFree;220.73
472;TCGA-B6-A0IB;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M1;T3;N3;stage IV;64;FEMALE;Dead;129.47;3941;NA;Recurred/Progressed;89.26
473;TCGA-B6-A0IC;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;MX;T2;NX;stage X;90;FEMALE;Dead;50.66;1542;NA;NA;NA
474;TCGA-B6-A0IE;TCGA Breast Carcinoma;Normal-like;Negative;Negative;Negative;1;NA;M0;TX;N1;stage Tis;38;FEMALE;Dead;65.67;1999;NA;Recurred/Progressed;27.6
475;TCGA-B6-A0IG;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Not Available;4;NA;M0;T2;N1;stage II;50;FEMALE;Dead;146.39;4456;NA;NA;NA
476;TCGA-B6-A0IH;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T3;N1;stage III;81;FEMALE;Dead;112.29;3418;NA;NA;NA
477;TCGA-B6-A0IJ;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Negative;5;2;M0;T3;N0 ;stage II;42;FEMALE;Alive;176.84;NA;5383;DiseaseFree;176.84
478;TCGA-B6-A0IK;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Negative;4;1;M0;T4;N1;stage III;63;FEMALE;Dead;18.76;571;NA;Recurred/Progressed;16.06
479;TCGA-B6-A0IM;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T3;N0 ;stage II;75;FEMALE;Alive;126.02;NA;3836;DiseaseFree;126.02
480;TCGA-B6-A0IN;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Not Available;4;NA;MX;T1;NX;stage X;45;FEMALE;Dead;84.53;2573;NA;Recurred/Progressed;46.39
481;TCGA-B6-A0IO;TCGA Breast Carcinoma;Luminal A;Positive;Indeterminate;Negative;2;3;M0;T2;N0 ;stage II;66;FEMALE;Alive;110.05;NA;3350;DiseaseFree;110.05
482;TCGA-B6-A0IP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T1;N0 ;stage I;74;FEMALE;Alive;110.84;NA;3374;DiseaseFree;110.84
483;TCGA-B6-A0IQ;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T3;N1;stage III;40;FEMALE;Alive;140.77;NA;3872;DiseaseFree;140.77
484;TCGA-B6-A0RE;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;TX;N0 ;stage X;61;FEMALE;Alive;211.4;NA;6435;DiseaseFree;211.4
485;TCGA-B6-A0RG;TCGA Breast Carcinoma;Luminal A;Negative;Negative;Negative;2;3;M0;T3;N0 ;stage II;26;FEMALE;Alive;68.4;NA;2082;DiseaseFree;68.4
486;TCGA-B6-A0RH;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;2;3;M0;T2;N0 ;stage II;51;FEMALE;Alive;188.86;NA;5749;Recurred/Progressed;71.12
487;TCGA-B6-A0RI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T4;N1;stage III;44;FEMALE;Alive;234.1;NA;6796;Recurred/Progressed;36.14
488;TCGA-B6-A0RL;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N0 ;stage II;60;FEMALE;Dead;81.11;2469;NA;NA;NA
489;TCGA-B6-A0RM;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;MX;TX;NX;stage X;57;FEMALE;Dead;77.96;2373;NA;NA;NA
490;TCGA-B6-A0RN;TCGA Breast Carcinoma;Luminal A;Negative;Negative;Negative;4;3;M0;T1;N0 ;stage I;60;FEMALE;Alive;172.83;NA;5261;DiseaseFree;172.83
491;TCGA-B6-A0RO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T4;N1;stage III;71;FEMALE;Alive;161.93;NA;4929;DiseaseFree;161.93
492;TCGA-B6-A0RP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage III;73;FEMALE;Dead;102.69;3126;NA;Recurred/Progressed;91.56
493;TCGA-B6-A0RQ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T3;N0 ;stage II;68;FEMALE;Dead;140.37;4273;NA;NA;NA
494;TCGA-B6-A0RS;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;38;FEMALE;Dead;100.62;3063;NA;Recurred/Progressed;67.05
495;TCGA-B6-A0RT;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T3;N1;stage III;39;FEMALE;Alive;89.39;NA;2721;DiseaseFree;89.39
496;TCGA-B6-A0RU;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0 ;stage I;49;FEMALE;Alive;131.11;NA;3991;DiseaseFree;131.11
497;TCGA-B6-A0RV;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T3;N2;stage III;42;FEMALE;Alive;157.29;NA;4788;DiseaseFree;157.29
498;TCGA-B6-A0WS;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;MX;T1;NX;stage X;58;FEMALE;Dead;97.4;2965;NA;NA;NA
499;TCGA-B6-A0WT;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;61;FEMALE;Alive;188.53;NA;5396;Recurred/Progressed;126.87
500;TCGA-B6-A0WV;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;67;FEMALE;Dead;79.57;2422;NA;NA;NA
501;TCGA-B6-A0WW;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;MX;T2;N1;stage X;58;FEMALE;Dead;18.33;558;547;Recurred/Progressed;14.68
502;TCGA-B6-A0WX;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T3;N1;stage III;40;FEMALE;Dead;21.45;653;NA;Recurred/Progressed;18.96
503;TCGA-B6-A0WY;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;1;NA;M0;T3;N1;stage III;40;FEMALE;Dead;113.7;3461;NA;Recurred/Progressed;66.06
504;TCGA-B6-A0WZ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;50;FEMALE;Alive;129.47;NA;3941;DiseaseFree;129.47
505;TCGA-B6-A0X0;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0 ;stage I;54;FEMALE;Dead;129.6;3945;NA;NA;NA
506;TCGA-B6-A0X1;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Not Available;5;NA;M1;T2;N2;stage IV;48;FEMALE;Alive;186.33;NA;5672;Recurred/Progressed;15.93
507;TCGA-B6-A0X4;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;62;FEMALE;Dead;28.25;860;NA;Recurred/Progressed;23.52
508;TCGA-B6-A0X5;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;61;FEMALE;Dead;68.89;2097;NA;Recurred/Progressed;44.12
509;TCGA-B6-A0X7;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;MX;T1;NX;stage X;62;FEMALE;Dead;58.84;1791;NA;Recurred/Progressed;36.6
510;TCGA-B6-A1KC;TCGA Breast Carcinoma;NA;Positive;Negative;Not Available;3;NA;M0;T2;N1;stage II;67;FEMALE;Alive;43.56;NA;1326;DiseaseFree;43.56
511;TCGA-B6-A1KF;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T2;N1;stage II;68;FEMALE;Alive;101.45;NA;3088;DiseaseFree;101.45
512;TCGA-B6-A1KI;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;63;FEMALE;Alive;73.46;NA;1463;DiseaseFree;73.46
513;TCGA-B6-A1KN;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;3;NA;M0;T4;N1;stage III;57;FEMALE;Alive;139.06;NA;3330;DiseaseFree;139.06
514;TCGA-B6-A2IU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;62;FEMALE;Alive;170.04;NA;4840;Recurred/Progressed;138.76
515;TCGA-B6-A3ZX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
516;TCGA-B6-A400;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
517;TCGA-B6-A401;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
518;TCGA-B6-A402;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0 ;stage I;47;FEMALE;Alive;54.24;NA;1651;Recurred/Progressed;49.8
519;TCGA-B6-A408;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;55;FEMALE;Alive;49.9;NA;1519;DiseaseFree;49.9
520;TCGA-B6-A409;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
521;TCGA-B6-A40B;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0 ;stage I;76;FEMALE;Alive;82.82;NA;2521;DiseaseFree;82.82
522;TCGA-B6-A40C;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0 ;stage II;51;FEMALE;Alive;54.96;NA;1673;DiseaseFree;54.96
523;TCGA-BH-A0AU;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;3;M0;T2;N0;stage II;45;FEMALE;Alive;24.51;NA;746;DiseaseFree;24.51
524;TCGA-BH-A0AV;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0;stage I;52;FEMALE;Alive;38.76;NA;1180;DiseaseFree;38.76
525;TCGA-BH-A0AW;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;1;NA;M0;T1;N1;stage II;56;FEMALE;Alive;20.43;NA;622;DiseaseFree;20.43
526;TCGA-BH-A0AY;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;3;M0;T2;N0 ;stage II;62;FEMALE;Alive;25.53;NA;777;DiseaseFree;25.53
527;TCGA-BH-A0AZ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0 ;T3;N1;stage III;47;FEMALE;Alive;28.48;NA;867;DiseaseFree;28.48
528;TCGA-BH-A0B0;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;56;FEMALE;Alive;46.91;NA;1428;DiseaseFree;46.91
529;TCGA-BH-A0B1;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;NA;NA;M0;T2;N1;stage II;66;FEMALE;Alive;37.71;NA;1148;DiseaseFree;37.71
530;TCGA-BH-A0B2;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;NA;NA;M0;T1;N0;stage I;43;FEMALE;Alive;40.8;NA;1242;DiseaseFree;40.8
531;TCGA-BH-A0B3;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;53;FEMALE;Alive;39.52;NA;1203;DiseaseFree;39.52
532;TCGA-BH-A0B4;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;4;3;M0;T2;N2;stage III;65;MALE;Alive;39.13;NA;1191;DiseaseFree;39.13
533;TCGA-BH-A0B5;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N2;stage III;40;FEMALE;Alive;48.32;NA;1471;DiseaseFree;48.32
534;TCGA-BH-A0B6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;47;FEMALE;Alive;56.9;NA;1732;DiseaseFree;56.9
535;TCGA-BH-A0B7;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;5;1;M0;T2;N1;stage II;42;FEMALE;Alive;56.93;NA;1733;DiseaseFree;56.93
536;TCGA-BH-A0B8;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;NA;M0;T1;N0 ;stage I;64;FEMALE;Alive;51.54;NA;1569;DiseaseFree;51.54
537;TCGA-BH-A0B9;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0 ;stage I;44;FEMALE;Alive;51.64;NA;1572;DiseaseFree;51.64
538;TCGA-BH-A0BA;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N3;stage III;51;FEMALE;Alive;37.19;NA;1132;DiseaseFree;37.19
539;TCGA-BH-A0BC;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N3;stage III;60;FEMALE;Alive;32;NA;974;DiseaseFree;32
540;TCGA-BH-A0BD;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T1;N1;stage II;47;FEMALE;Alive;18.2;NA;554;DiseaseFree;18.2
541;TCGA-BH-A0BF;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;4;M0;T2;N1;stage II;56;FEMALE;Alive;25.69;NA;782;DiseaseFree;25.69
542;TCGA-BH-A0BG;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T1;N0;stage I;73;FEMALE;Alive;24.84;NA;756;DiseaseFree;24.84
543;TCGA-BH-A0BJ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;41;FEMALE;Alive;21.68;NA;660;DiseaseFree;21.68
544;TCGA-BH-A0BL;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T1;N0;stage I;35;FEMALE;Alive;44.02;NA;1340;DiseaseFree;44.02
545;TCGA-BH-A0BM;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;2;3;M0;T2;N1;stage II;54;FEMALE;Alive;61.63;NA;1117;DiseaseFree;61.63
546;TCGA-BH-A0BO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;54;FEMALE;Alive;35.64;NA;1085;DiseaseFree;35.64
547;TCGA-BH-A0BP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0;stage I;76;FEMALE;Alive;48.65;NA;1481;DiseaseFree;48.65
548;TCGA-BH-A0BQ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;39;FEMALE;Alive;27.17;NA;827;DiseaseFree;27.17
549;TCGA-BH-A0BR;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0;stage I;59;FEMALE;Alive;53.65;NA;1633;DiseaseFree;53.65
550;TCGA-BH-A0BS;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T3;N1;stage III;55;FEMALE;Alive;53.91;NA;1641;DiseaseFree;53.91
551;TCGA-BH-A0BT;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N1;stage II;56;FEMALE;Alive;45.53;NA;1386;DiseaseFree;45.53
552;TCGA-BH-A0BV;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N1;stage II;78;FEMALE;Alive;49.9;NA;1519;DiseaseFree;49.9
553;TCGA-BH-A0BW;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N0;stage I;71;FEMALE;Alive;11.66;NA;355;DiseaseFree;11.66
554;TCGA-BH-A0BZ;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T3;N1;stage III;59;FEMALE;Alive;49.01;NA;1492;DiseaseFree;49.01
555;TCGA-BH-A0C0;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;4;4;M0;T1;N1;stage II;62;FEMALE;Alive;41.72;NA;1270;DiseaseFree;41.72
556;TCGA-BH-A0C1;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N2;stage III;61;FEMALE;Alive;43.99;NA;1339;DiseaseFree;43.99
557;TCGA-BH-A0C3;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;2;4;M0;T1;N0;stage I;47;FEMALE;Alive;48.09;NA;1464;DiseaseFree;48.09
558;TCGA-BH-A0C7;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;4;4;M0;T2;N1;stage II;48;FEMALE;Alive;42.87;NA;1305;DiseaseFree;42.87
559;TCGA-BH-A0DD;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;4;4;M0;T2;N1;stage II;58;MALE;Alive;45.8;NA;1394;DiseaseFree;45.8
560;TCGA-BH-A0DE;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;62;FEMALE;Alive;31.14;NA;948;DiseaseFree;31.14
561;TCGA-BH-A0DG;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;1;3;M0;T2;N0;stage II;30;FEMALE;Alive;23.42;NA;713;DiseaseFree;23.42
562;TCGA-BH-A0DH;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T2;N1;stage II;63;FEMALE;Alive;37.98;NA;1156;DiseaseFree;37.98
563;TCGA-BH-A0DI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N1;stage II;63;FEMALE;Alive;22.11;NA;673;DiseaseFree;22.11
564;TCGA-BH-A0DK;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T2;N0 ;stage II;49;FEMALE;Alive;13.9;NA;423;DiseaseFree;13.9
565;TCGA-BH-A0DL;TCGA Breast Carcinoma;Basal-like;Positive;Negative;Negative;5;2;M0;T2;N0;stage II;64;FEMALE;Alive;48.19;NA;1467;DiseaseFree;48.19
566;TCGA-BH-A0DO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;78;FEMALE;Alive;17.25;NA;525;DiseaseFree;17.25
567;TCGA-BH-A0DP;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T3;N0 ;stage II;60;FEMALE;Alive;15.64;NA;476;DiseaseFree;15.64
568;TCGA-BH-A0DQ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;42;FEMALE;Alive;3.22;NA;98;DiseaseFree;3.22
569;TCGA-BH-A0DS;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T2;N2;stage III;71;FEMALE;Alive;2.56;NA;78;DiseaseFree;2.56
570;TCGA-BH-A0DT;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N1;stage II;41;FEMALE;Alive;38.44;NA;1170;DiseaseFree;38.44
571;TCGA-BH-A0DV;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N2;stage III;54;FEMALE;Alive;45.14;NA;1374;DiseaseFree;45.14
572;TCGA-BH-A0DX;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;62;FEMALE;Alive;47.37;NA;1442;DiseaseFree;47.37
573;TCGA-BH-A0DZ;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;4;NA;M0;T2;N1;stage II;43;FEMALE;Alive;16.26;NA;495;DiseaseFree;16.26
574;TCGA-BH-A0E0;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T3;N3;stage III;38;FEMALE;Alive;4.4;NA;134;DiseaseFree;4.4
575;TCGA-BH-A0E1;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;52;FEMALE;Alive;15.67;NA;477;DiseaseFree;15.67
576;TCGA-BH-A0E2;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N2;stage III;49;FEMALE;Alive;14.29;NA;376;DiseaseFree;14.29
577;TCGA-BH-A0E6;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;1;3;M0;T1;N0 ;stage I;69;FEMALE;Alive;9.63;NA;293;DiseaseFree;9.63
578;TCGA-BH-A0E7;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;79;FEMALE;Alive;44.78;NA;1363;DiseaseFree;44.78
579;TCGA-BH-A0E9;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N1;stage II;53;FEMALE;Alive;46.16;NA;1405;DiseaseFree;46.16
580;TCGA-BH-A0EA;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N1;stage II;72;FEMALE;Dead;32.62;993;NA;NA;NA
581;TCGA-BH-A0EB;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;69;FEMALE;Alive;24.47;NA;745;DiseaseFree;24.47
582;TCGA-BH-A0EE;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T3;N0 ;stage II;68;FEMALE;Alive;30.98;NA;943;DiseaseFree;30.98
583;TCGA-BH-A0EI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N1;stage II;51;FEMALE;Alive;24.41;NA;743;DiseaseFree;24.41
584;TCGA-BH-A0GY;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;67;FEMALE;Alive;30.32;NA;917;DiseaseFree;30.32
585;TCGA-BH-A0GZ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T1;N1;stage II;62;FEMALE;Alive;10.78;NA;328;DiseaseFree;10.78
586;TCGA-BH-A0H0;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T1;N0 ;stage I;69;FEMALE;Alive;15.14;NA;461;DiseaseFree;15.14
587;TCGA-BH-A0H3;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;46;FEMALE;Alive;37.75;NA;1149;DiseaseFree;37.75
588;TCGA-BH-A0H5;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;1;M0;T1;N0 ;stage I;45;FEMALE;Alive;35.48;NA;1080;DiseaseFree;35.48
589;TCGA-BH-A0H6;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;NX;stage I;82;FEMALE;Alive;24.54;NA;747;DiseaseFree;24.54
590;TCGA-BH-A0H7;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N2;stage III;65;FEMALE;Alive;23.06;NA;702;DiseaseFree;23.06
591;TCGA-BH-A0H9;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;5;2;M0;T2;N0 ;stage II;69;FEMALE;Alive;40.97;NA;1247;DiseaseFree;40.97
592;TCGA-BH-A0HA;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0 ;stage I;31;FEMALE;Alive;52.92;NA;856;DiseaseFree;52.92
593;TCGA-BH-A0HB;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;55;FEMALE;Alive;26.48;NA;806;DiseaseFree;26.48
594;TCGA-BH-A0HF;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0 ;stage I;77;FEMALE;Alive;23.88;NA;727;DiseaseFree;23.88
595;TCGA-BH-A0HI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0 ;stage I;78;FEMALE;Alive;20.37;NA;620;DiseaseFree;20.37
596;TCGA-BH-A0HK;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;3;3;M0;T2;N1;stage II;81;FEMALE;Alive;5.85;NA;178;DiseaseFree;5.85
597;TCGA-BH-A0HL;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Negative;3;NA;M0;T2;N1;stage II;56;FEMALE;Alive;2.37;NA;72;DiseaseFree;2.37
598;TCGA-BH-A0HN;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Negative;2;NA;M0;T1;N0 ;stage I;67;FEMALE;Alive;16.95;NA;516;DiseaseFree;16.95
599;TCGA-BH-A0HO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N1;stage II;48;FEMALE;Alive;2.5;NA;76;DiseaseFree;2.5
600;TCGA-BH-A0HP;TCGA Breast Carcinoma;Luminal A;Positive;Negative;Negative;1;3;M0;T3;N2;stage III;65;FEMALE;Alive;13.6;NA;414;DiseaseFree;13.6
601;TCGA-BH-A0HQ;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;56;FEMALE;Alive;36.83;NA;1121;DiseaseFree;36.83
602;TCGA-BH-A0HU;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T1;N0 ;stage I;52;FEMALE;Alive;12.88;NA;392;DiseaseFree;12.88
603;TCGA-BH-A0HW;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;2;4;M0;T1;N0 ;stage I;62;FEMALE;Alive;51.28;NA;1561;DiseaseFree;51.28
604;TCGA-BH-A0HX;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N1;stage II;54;FEMALE;Alive;27.23;NA;829;DiseaseFree;27.23
605;TCGA-BH-A0HY;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Not Available;3;NA;M0;T1;N0;stage I;60;FEMALE;Alive;50.76;NA;868;DiseaseFree;50.76
606;TCGA-BH-A0RX;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0 ;stage II;59;FEMALE;Alive;5.58;NA;170;DiseaseFree;5.58
607;TCGA-BH-A0W3;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T1;N1;stage II;58;FEMALE;Alive;23.92;NA;180;DiseaseFree;23.92
608;TCGA-BH-A0W4;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;46;FEMALE;Alive;24.93;NA;175;DiseaseFree;24.93
609;TCGA-BH-A0W5;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N1;stage II;77;FEMALE;Alive;42.31;NA;543;DiseaseFree;42.31
610;TCGA-BH-A0W7;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0 ;stage I;49;FEMALE;Alive;44.78;NA;558;DiseaseFree;44.78
611;TCGA-BH-A0WA;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T1;N0 ;stage I;82;FEMALE;Alive;23.03;NA;372;DiseaseFree;23.03
612;TCGA-BH-A18F;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;3;M0;T2;N0;stage II;50;FEMALE;Alive;8.8;NA;268;DiseaseFree;8.8
613;TCGA-BH-A18G;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;4;NA;M0;T1;N0;stage I;81;FEMALE;Alive;2;NA;61;DiseaseFree;2
614;TCGA-BH-A18H;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;63;FEMALE;Alive;0;NA;0;DiseaseFree;0
615;TCGA-BH-A18I;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0 ;T1;N1;stage II;53;FEMALE;Alive;7.23;NA;220;DiseaseFree;7.23
616;TCGA-BH-A18J;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;4;M1;T4;N2;stage IV;56;FEMALE;Dead;20.11;612;NA;NA;NA
617;TCGA-BH-A18K;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;46;FEMALE;Dead;90.77;2763;NA;NA;NA
618;TCGA-BH-A18L;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Not Available;4;4;M0;T3;N1;stage III;50;FEMALE;Dead;26.64;811;NA;NA;NA
619;TCGA-BH-A18M;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;1;3;M0;T3;N1;stage III;39;FEMALE;Dead;72.5;2207;NA;NA;NA
620;TCGA-BH-A18N;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;88;FEMALE;Dead;37.71;1148;NA;NA;NA
621;TCGA-BH-A18P;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Negative;4;1;M0;T1;N0;stage I;60;FEMALE;Dead;30.26;921;NA;NA;NA
622;TCGA-BH-A18Q;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;56;FEMALE;Dead;55.58;1692;NA;NA;NA
623;TCGA-BH-A18R;TCGA Breast Carcinoma;HER2-enriched;Indeterminate;Negative;Positive;4;1;M0;T2;N1;stage II;50;FEMALE;Dead;37.52;1142;NA;NA;NA
624;TCGA-BH-A18S;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Not Available;2;3;M0;T1;N0;stage I;79;FEMALE;Dead;66;2009;NA;NA;NA
625;TCGA-BH-A18T;TCGA Breast Carcinoma;Luminal A;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;70;FEMALE;Dead;7.36;224;NA;NA;NA
626;TCGA-BH-A18U;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;4;M0;T2;N2;stage III;72;FEMALE;Dead;51.35;1563;NA;NA;NA
627;TCGA-BH-A18V;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;48;FEMALE;Dead;51.12;1556;NA;NA;NA
628;TCGA-BH-A18V;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N1;stage II;48;FEMALE;Dead;51.12;1556;NA;NA;NA
629;TCGA-BH-A1EN;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;3;NA;M0;T2;NX;stage II;78;FEMALE;Dead;67.44;2053;NA;NA;NA
630;TCGA-BH-A1EO;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T1;N1;stage II;68;FEMALE;Dead;91.92;2798;NA;NA;NA
631;TCGA-BH-A1ES;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;35;FEMALE;Dead;113.73;3462;NA;NA;NA
632;TCGA-BH-A1ES;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;35;FEMALE;Dead;113.73;3462;NA;NA;NA
633;TCGA-BH-A1ET;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;55;FEMALE;Dead;82.79;2520;NA;NA;NA
634;TCGA-BH-A1EU;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;83;FEMALE;Dead;42.25;1286;NA;NA;NA
635;TCGA-BH-A1EV;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;NA;2;NA;M0;T3;N1;stage III;45;FEMALE;Dead;11.99;365;NA;NA;NA
636;TCGA-BH-A1EW;TCGA Breast Carcinoma;Luminal B;Negative;Negative;Negative;1;NA;M0;T2;N1;stage II;38;FEMALE;Dead;55.65;1694;NA;NA;NA
637;TCGA-BH-A1EX;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;67;FEMALE;Dead;49.54;1508;NA;NA;NA
638;TCGA-BH-A1EY;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;79;FEMALE;Dead;17.67;538;NA;NA;NA
639;TCGA-BH-A1F0;TCGA Breast Carcinoma;Basal-like;Negative;Indeterminate;Negative;5;NA;M0;T1;N1;stage II;80;FEMALE;Dead;25.79;785;NA;NA;NA
640;TCGA-BH-A1F2;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;2;NA;M0;T4;N1;stage III;53;FEMALE;Dead;31.5;959;NA;NA;NA
641;TCGA-BH-A1F5;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T1;N1;stage II;62;FEMALE;Dead;89.09;2712;NA;NA;NA
642;TCGA-BH-A1F6;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;MX;T4d;N2;;51;FEMALE;Dead;97.4;2965;NA;NA;NA
643;TCGA-BH-A1F8;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T4;N2;stage III;90;FEMALE;Dead;24.61;749;NA;NA;NA
644;TCGA-BH-A1FB;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;60;FEMALE;Dead;120.53;3669;NA;NA;NA
645;TCGA-BH-A1FC;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T1;N1;stage II;78;FEMALE;Dead;114.06;3472;NA;NA;NA
646;TCGA-BH-A1FD;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T1;N0;stage I;68;FEMALE;Dead;33.15;1009;NA;NA;NA
647;TCGA-BH-A1FE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;31;FEMALE;Dead;74.67;2273;NA;NA;NA
648;TCGA-BH-A1FE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;31;FEMALE;Dead;74.67;2273;NA;NA;NA
649;TCGA-BH-A1FG;TCGA Breast Carcinoma;NA;Positive;Positive;Not Available;2;NA;M0;T1;NX;stage I;88;FEMALE;Dead;122.8;3738;NA;NA;NA
650;TCGA-BH-A1FH;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;1;NA;M1;T2;N1;stage IV;47;FEMALE;Dead;36.89;1123;NA;NA;NA
651;TCGA-BH-A1FJ;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;4;NA;M0;T3;N1;stage III;66;FEMALE;Dead;63.3;1927;NA;NA;NA
652;TCGA-BH-A1FL;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;69;FEMALE;Dead;54.96;1673;NA;NA;NA
653;TCGA-BH-A1FM;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;3;NA;M0;T2;N2;stage III;44;FEMALE;Dead;45.6;1388;NA;NA;NA
654;TCGA-BH-A1FN;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T2;N0;stage II;34;FEMALE;Dead;72.01;2192;NA;NA;NA
655;TCGA-BH-A1FR;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T4;N1;stage III;73;FEMALE;Dead;144.48;4398;NA;NA;NA
656;TCGA-BH-A1FU;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;1;NA;M0;T1;N0;stage I;44;FEMALE;Dead;72.01;2192;NA;NA;NA
657;TCGA-BH-A201;TCGA Breast Carcinoma;NA;Positive;Positive;NA;4;NA;M0;T1;N0;stage I;64;FEMALE;Alive;6.9;NA;210;DiseaseFree;6.9
658;TCGA-BH-A202;TCGA Breast Carcinoma;NA;Positive;Positive;NA;4;NA;M0;T2;N0;stage II;60;FEMALE;Alive;0.72;NA;22;DiseaseFree;0.72
659;TCGA-BH-A203;TCGA Breast Carcinoma;NA;Performed but Not Available;Performed but Not Available;NA;3;NA;M0;T2;N1;stage II;78;FEMALE;Dead;38.57;1174;NA;NA;NA
660;TCGA-BH-A204;TCGA Breast Carcinoma;NA;Performed but Not Available;Performed but Not Available;NA;3;NA;M0;T2;N1;stage II;80;FEMALE;Dead;83.25;2534;NA;NA;NA
661;TCGA-BH-A208;TCGA Breast Carcinoma;NA;Performed but Not Available;Performed but Not Available;NA;5;NA;M0;T2;N1;stage II;48;FEMALE;Dead;57.79;1759;NA;NA;NA
662;TCGA-BH-A209;TCGA Breast Carcinoma;NA;Positive;Positive;NA;3;NA;M0;T1;N0;stage I;77;FEMALE;Dead;130.06;3959;NA;NA;NA
663;TCGA-BH-A28O;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;50;FEMALE;Alive;10.64;NA;324;DiseaseFree;10.64
664;TCGA-BH-A28Q;TCGA Breast Carcinoma;NA;Positive;Positive;NA;4;NA;M0;T2;N1;stage II;46;FEMALE;Alive;6.44;NA;196;DiseaseFree;6.44
665;TCGA-BH-A2L8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;45;FEMALE;Alive;20.11;NA;168;DiseaseFree;20.11
666;TCGA-BH-A42T;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;75;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
667;TCGA-BH-A42U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;80;FEMALE;Alive;109.2;NA;3324;DiseaseFree;109.2
668;TCGA-BH-A42V;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N1;stage I;41;FEMALE;Alive;8.94;NA;272;Recurred/Progressed;1.08
669;TCGA-BH-A5IZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
670;TCGA-BH-A5J0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
671;TCGA-BH-A6R8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
672;TCGA-BH-A6R9;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
673;TCGA-BH-A8FY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
674;TCGA-BH-A8FZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
675;TCGA-BH-A8G0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
676;TCGA-BH-AB28;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
677;TCGA-C8-A12K;TCGA Breast Carcinoma;Basal-like;Not Performed;Not Performed;Negative;5;2;M0;T2;N1;stage II;80;FEMALE;Alive;0;NA;0;DiseaseFree;0
678;TCGA-C8-A12L;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;1;M0;T2;N0 ;stage II;67;FEMALE;Alive;11.93;NA;0;DiseaseFree;11.93
679;TCGA-C8-A12M;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Not Available;3;4;M0;T2;N0 ;stage II;70;FEMALE;Alive;11.76;NA;0;DiseaseFree;11.76
680;TCGA-C8-A12N;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N0 ;stage II;58;FEMALE;Alive;11.76;NA;0;DiseaseFree;11.76
681;TCGA-C8-A12O;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Not Available;1;NA;M0;T2;N0 ;stage II;50;FEMALE;Alive;12.65;NA;0;DiseaseFree;12.65
682;TCGA-C8-A12P;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T2;N1;stage II;55;FEMALE;Alive;11.76;NA;0;DiseaseFree;11.76
683;TCGA-C8-A12Q;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;2;1;M0;T1;N2;stage III;78;FEMALE;Dead;12.65;NA;2;NA;NA
684;TCGA-C8-A12T;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;4;1;M0;T2;N0;stage II;43;FEMALE;Alive;0;NA;0;DiseaseFree;0
685;TCGA-C8-A12U;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;46;FEMALE;Alive;12.65;NA;0;DiseaseFree;12.65
686;TCGA-C8-A12V;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;55;FEMALE;Alive;12.65;NA;0;DiseaseFree;12.65
687;TCGA-C8-A12W;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T4;N1;stage III;49;FEMALE;Alive;12.65;NA;7;DiseaseFree;12.65
688;TCGA-C8-A12X;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;3;4;M0;T2;N1;stage II;62;FEMALE;Alive;12.65;NA;0;DiseaseFree;12.65
689;TCGA-C8-A12Y;TCGA Breast Carcinoma;Luminal A;Not Performed;Not Performed;Negative;2;3;M0;T2;N1;stage II;44;FEMALE;Alive;0;NA;0;DiseaseFree;0
690;TCGA-C8-A12Z;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;1;M0;T2;N1;stage II;45;FEMALE;Alive;0;NA;0;DiseaseFree;0
691;TCGA-C8-A130;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Equivocal;2;1;M0;T3;N2;stage III;52;FEMALE;Alive;3.12;NA;3;DiseaseFree;3.12
692;TCGA-C8-A131;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;1;2;M0;T2;N2;stage III;82;FEMALE;Alive;1.77;NA;0;DiseaseFree;1.77
693;TCGA-C8-A132;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;1;3;M0;T2;N1;stage II;56;FEMALE;Alive;1.45;NA;0;DiseaseFree;1.45
694;TCGA-C8-A133;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T3;N1;stage III;65;FEMALE;Alive;0;NA;0;DiseaseFree;0
695;TCGA-C8-A134;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;4;2;M0;T2;N0;stage II;52;FEMALE;Alive;0.69;NA;1;DiseaseFree;0.69
696;TCGA-C8-A135;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T2;N1;stage II;64;FEMALE;Alive;0.62;NA;0;DiseaseFree;0.62
697;TCGA-C8-A137;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;4;NA;M0;T2;N1;stage II;34;FEMALE;Alive;3.84;NA;26;DiseaseFree;3.84
698;TCGA-C8-A138;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;2;1;M0;T2;N2;stage III;54;FEMALE;Alive;3.75;NA;-3;DiseaseFree;3.75
699;TCGA-C8-A1HE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;59;FEMALE;Alive;12.32;NA;0;DiseaseFree;12.32
700;TCGA-C8-A1HF;TCGA Breast Carcinoma;HER2-enriched;Negative;Positive;Positive;2;NA;M0;T2;N0;stage II;48;FEMALE;Alive;10.91;NA;0;DiseaseFree;10.91
701;TCGA-C8-A1HG;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;5;NA;M0;T2;N0;stage II;50;FEMALE;Alive;11.33;NA;0;DiseaseFree;11.33
702;TCGA-C8-A1HI;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N2;stage III;40;FEMALE;Alive;11.33;NA;2;DiseaseFree;11.33
703;TCGA-C8-A1HJ;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;53;FEMALE;Alive;0.16;NA;5;DiseaseFree;0.16
704;TCGA-C8-A1HK;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T2;N1;stage II;53;FEMALE;Alive;12.02;NA;7;DiseaseFree;12.02
705;TCGA-C8-A1HL;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Positive;2;NA;M0;T3;N1;stage III;38;FEMALE;Alive;10.41;NA;2;DiseaseFree;10.41
706;TCGA-C8-A1HM;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;74;FEMALE;Alive;2.3;NA;6;DiseaseFree;2.3
707;TCGA-C8-A1HN;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Equivocal;2;NA;M0;T2;N0;stage II;56;FEMALE;Alive;3.25;NA;2;DiseaseFree;3.25
708;TCGA-C8-A1HO;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T3;N3;stage III;34;FEMALE;Alive;0;NA;0;DiseaseFree;0
709;TCGA-C8-A26V;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T3;N2;stage III;47;FEMALE;Alive;0.3;NA;9;DiseaseFree;0.3
710;TCGA-C8-A26W;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;1;NA;M0;T2;N1;stage II;58;FEMALE;Alive;0.23;NA;7;DiseaseFree;0.23
711;TCGA-C8-A26X;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T1;N1;stage II;58;FEMALE;Alive;0.36;NA;11;DiseaseFree;0.36
712;TCGA-C8-A26Y;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T2;N0;stage II;90;FEMALE;Alive;0.43;NA;13;DiseaseFree;0.43
713;TCGA-C8-A26Z;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;59;FEMALE;Alive;8.28;NA;4;DiseaseFree;8.28
714;TCGA-C8-A273;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;29;FEMALE;Alive;9.66;NA;6;DiseaseFree;9.66
715;TCGA-C8-A274;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;63;FEMALE;Alive;0.03;NA;1;DiseaseFree;0.03
716;TCGA-C8-A275;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Positive;4;NA;M0;T1;N1;stage II;56;FEMALE;Alive;0.03;NA;1;DiseaseFree;0.03
717;TCGA-C8-A278;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T2;N2;stage III;61;FEMALE;Alive;0.03;NA;1;DiseaseFree;0.03
718;TCGA-C8-A27A;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N1;stage II;48;FEMALE;Alive;12.19;NA;371;DiseaseFree;12.19
719;TCGA-C8-A27B;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T3;N0;stage II;48;FEMALE;Alive;0.99;NA;30;DiseaseFree;0.99
720;TCGA-C8-A3M7;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T4;N0;stage III;60;FEMALE;Alive;0.03;NA;1;DiseaseFree;0.03
721;TCGA-C8-A3M8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;68;FEMALE;Alive;0.23;NA;7;DiseaseFree;0.23
722;TCGA-C8-A8HP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
723;TCGA-C8-A8HQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
724;TCGA-C8-A8HR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
725;TCGA-C8-A9FZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
726;TCGA-D8-A13Y;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T1;N0;stage I;52;FEMALE;Alive;11.89;NA;264;DiseaseFree;11.89
727;TCGA-D8-A13Z;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Negative;1;1;M0;T2;N2;stage X;51;FEMALE;Alive;20.86;NA;210;DiseaseFree;20.86
728;TCGA-D8-A140;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;3;NA;M0;T2;N1;stage II;62;FEMALE;Alive;13.24;NA;27;DiseaseFree;13.24
729;TCGA-D8-A141;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T1;N1;stage X;40;FEMALE;Alive;20.57;NA;113;DiseaseFree;20.57
730;TCGA-D8-A142;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T3;N0;stage II;74;FEMALE;Alive;13.96;NA;61;DiseaseFree;13.96
731;TCGA-D8-A143;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;51;FEMALE;Alive;14.16;NA;172;DiseaseFree;14.16
732;TCGA-D8-A145;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N1;stage II;80;FEMALE;Alive;13.47;NA;49;DiseaseFree;13.47
733;TCGA-D8-A146;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;NA;NA;MX;T2;N0;stage II;57;FEMALE;Alive;21.12;NA;344;DiseaseFree;21.12
734;TCGA-D8-A147;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage X;45;FEMALE;Alive;19.19;NA;2;DiseaseFree;19.19
735;TCGA-D8-A1J8;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N1;stage II;77;FEMALE;Alive;14.16;NA;256;DiseaseFree;14.16
736;TCGA-D8-A1J9;TCGA Breast Carcinoma;NA;Positive;Negative;Positive;3;NA;M0;T1;N0;stage I;48;FEMALE;Alive;17.48;NA;248;DiseaseFree;17.48
737;TCGA-D8-A1JA;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T4;NX;stage X;60;FEMALE;Alive;16.49;NA;18;Recurred/Progressed;14.16
738;TCGA-D8-A1JB;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;1;NA;M0;T2;N1;stage II;54;FEMALE;Alive;18.69;NA;0;DiseaseFree;18.69
739;TCGA-D8-A1JC;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N2;stage III;59;FEMALE;Alive;15.77;NA;178;DiseaseFree;15.77
740;TCGA-D8-A1JD;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;41;FEMALE;Alive;18.13;NA;273;DiseaseFree;18.13
741;TCGA-D8-A1JE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N1;stage II;62;FEMALE;Alive;18.89;NA;57;DiseaseFree;18.89
742;TCGA-D8-A1JF;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;1;NA;M0;T1;N2;stage III;79;FEMALE;Alive;12.02;NA;96;DiseaseFree;12.02
743;TCGA-D8-A1JG;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T2;N0;stage II;62;FEMALE;Alive;12.02;NA;187;DiseaseFree;12.02
744;TCGA-D8-A1JH;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;56;FEMALE;Alive;13.99;NA;284;DiseaseFree;13.99
745;TCGA-D8-A1JI;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T1;N1;stage II;54;FEMALE;Alive;18.96;NA;21;DiseaseFree;18.96
746;TCGA-D8-A1JJ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;54;FEMALE;Alive;20.07;NA;274;DiseaseFree;20.07
747;TCGA-D8-A1JK;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;1;NA;M0;T2;N0;stage II;90;FEMALE;Alive;20.11;NA;109;DiseaseFree;20.11
748;TCGA-D8-A1JL;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;72;FEMALE;Alive;20.07;NA;265;DiseaseFree;20.07
749;TCGA-D8-A1JM;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;4;NA;M0;T2;N1;stage II;59;FEMALE;Alive;19.38;NA;238;DiseaseFree;19.38
750;TCGA-D8-A1JN;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;MX;T3;N3;stage III;80;FEMALE;Alive;20.37;NA;217;DiseaseFree;20.37
751;TCGA-D8-A1JP;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T1;N0;stage I;73;FEMALE;Alive;20.99;NA;167;DiseaseFree;20.99
752;TCGA-D8-A1JS;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;77;FEMALE;Alive;12.19;NA;105;DiseaseFree;12.19
753;TCGA-D8-A1JT;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;70;FEMALE;Alive;13.3;NA;123;DiseaseFree;13.3
754;TCGA-D8-A1JU;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T1;N0;stage I;51;FEMALE;Alive;14.68;NA;106;DiseaseFree;14.68
755;TCGA-D8-A1X5;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;MX;T2;N3;stage III;81;FEMALE;Alive;18.56;NA;171;DiseaseFree;18.56
756;TCGA-D8-A1X6;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T3;N2;stage III;80;FEMALE;Alive;17.77;NA;236;DiseaseFree;17.77
757;TCGA-D8-A1X7;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T2;N0;stage II;40;FEMALE;Alive;16.72;NA;85;DiseaseFree;16.72
758;TCGA-D8-A1X8;TCGA Breast Carcinoma;NA;Positive;Indeterminate;Negative;4;NA;M0;T1;N2;stage III;62;FEMALE;Alive;25.72;NA;272;DiseaseFree;25.72
759;TCGA-D8-A1X9;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N1;stage II;66;FEMALE;Alive;23.88;NA;380;DiseaseFree;23.88
760;TCGA-D8-A1XA;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;64;FEMALE;Alive;27.56;NA;274;DiseaseFree;27.56
761;TCGA-D8-A1XB;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;62;FEMALE;Alive;18.13;NA;201;DiseaseFree;18.13
762;TCGA-D8-A1XC;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T4;N1;stage III;85;FEMALE;Dead;12.39;NA;81;Recurred/Progressed;14.65
763;TCGA-D8-A1XD;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N2;stage III;36;FEMALE;Alive;17.15;NA;155;DiseaseFree;17.15
764;TCGA-D8-A1XF;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;45;FEMALE;Alive;15.21;NA;97;DiseaseFree;15.21
765;TCGA-D8-A1XG;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;2;NA;M0;T4;N1;stage III;86;FEMALE;Alive;14.72;NA;75;DiseaseFree;14.72
766;TCGA-D8-A1XJ;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;MX;T3;N1;stage III;76;FEMALE;Alive;21.81;NA;352;DiseaseFree;21.81
767;TCGA-D8-A1XK;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;MX;T2;N1;stage II;55;FEMALE;Alive;14.49;NA;326;DiseaseFree;14.49
768;TCGA-D8-A1XL;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T2;N1;stage II;34;FEMALE;Alive;19.91;NA;319;DiseaseFree;19.91
769;TCGA-D8-A1XM;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;57;FEMALE;Alive;17.67;NA;218;DiseaseFree;17.67
770;TCGA-D8-A1XO;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;56;FEMALE;Alive;7.95;NA;242;DiseaseFree;7.95
771;TCGA-D8-A1XQ;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;69;FEMALE;Alive;16.39;NA;177;DiseaseFree;16.39
772;TCGA-D8-A1XR;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;56;FEMALE;Alive;15.83;NA;168;DiseaseFree;15.83
773;TCGA-D8-A1XS;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;2;NA;M0;T2;N3;stage III;48;MALE;Alive;16.29;NA;50;DiseaseFree;16.29
774;TCGA-D8-A1XT;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T1;N1;stage II;61;FEMALE;Alive;6.34;NA;193;DiseaseFree;6.34
775;TCGA-D8-A1XU;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T1;N0;stage I;56;FEMALE;Alive;12.98;NA;150;DiseaseFree;12.98
776;TCGA-D8-A1XV;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;84;FEMALE;Alive;15.14;NA;147;DiseaseFree;15.14
777;TCGA-D8-A1XW;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;5;NA;M0;T2;N0;stage II;53;FEMALE;Alive;12.65;NA;118;DiseaseFree;12.65
778;TCGA-D8-A1XY;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;2;NA;MX;T2;N0;stage II;74;FEMALE;Alive;16.52;NA;81;DiseaseFree;16.52
779;TCGA-D8-A1XZ;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;4;NA;MX;T1;N2;stage III;81;FEMALE;Alive;15.31;NA;121;DiseaseFree;15.31
780;TCGA-D8-A1Y0;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T1;N2;stage III;65;FEMALE;Alive;15.51;NA;167;DiseaseFree;15.51
781;TCGA-D8-A1Y1;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;MX;T3;N1;stage III;80;FEMALE;Dead;9.92;NA;116;NA;NA
782;TCGA-D8-A1Y2;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T2;N0;stage II;71;FEMALE;Alive;14.22;NA;73;DiseaseFree;14.22
783;TCGA-D8-A1Y3;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;MX;T2;N2;stage III;61;FEMALE;Alive;14.13;NA;125;DiseaseFree;14.13
784;TCGA-D8-A27E;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T1;N0;stage I;66;FEMALE;Alive;17.41;NA;182;DiseaseFree;17.41
785;TCGA-D8-A27F;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;40;FEMALE;Alive;16.03;NA;106;DiseaseFree;16.03
786;TCGA-D8-A27G;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;75;FEMALE;Alive;13.44;NA;210;DiseaseFree;13.44
787;TCGA-D8-A27H;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;72;FEMALE;Alive;13.04;NA;19;DiseaseFree;13.04
788;TCGA-D8-A27I;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N2;stage III;58;FEMALE;Alive;14.42;NA;186;DiseaseFree;14.42
789;TCGA-D8-A27K;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;47;FEMALE;Alive;9.43;NA;119;DiseaseFree;9.43
790;TCGA-D8-A27L;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N2;stage III;49;FEMALE;Alive;16.39;NA;126;DiseaseFree;16.39
791;TCGA-D8-A27M;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T1;N0;stage I;59;FEMALE;Alive;13.47;NA;145;DiseaseFree;13.47
792;TCGA-D8-A27N;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;M0;T2;N2;stage III;36;FEMALE;Alive;4.8;NA;146;DiseaseFree;4.8
793;TCGA-D8-A27P;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;64;FEMALE;Alive;0.76;NA;23;DiseaseFree;0.76
794;TCGA-D8-A27R;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N3;stage III;41;FEMALE;Alive;10.09;NA;29;DiseaseFree;10.09
795;TCGA-D8-A27T;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N3;stage III;53;FEMALE;Alive;13.07;NA;136;DiseaseFree;13.07
796;TCGA-D8-A27V;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;62;FEMALE;Alive;12.52;NA;73;DiseaseFree;12.52
797;TCGA-D8-A27W;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;M0;T4;N0;stage III;55;FEMALE;Alive;12.25;NA;15;DiseaseFree;12.25
798;TCGA-D8-A3Z5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;54;FEMALE;Alive;14.49;NA;441;DiseaseFree;14.49
799;TCGA-D8-A3Z6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;56;FEMALE;Alive;6.08;NA;185;DiseaseFree;6.08
800;TCGA-D8-A4Z1;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;68;FEMALE;Alive;7.33;NA;223;DiseaseFree;7.33
801;TCGA-D8-A73U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
802;TCGA-D8-A73W;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
803;TCGA-D8-A73X;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
804;TCGA-E2-A105;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Equivocal;3;NA;M0;T2;N0 ;stage II;79;FEMALE;Alive;42.97;NA;1163;DiseaseFree;42.97
805;TCGA-E2-A106;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T1;N1;stage I;34;FEMALE;Alive;59.36;NA;1555;DiseaseFree;59.36
806;TCGA-E2-A107;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;4;M0;T3;N2;stage III;54;FEMALE;Alive;34.4;NA;763;DiseaseFree;34.4
807;TCGA-E2-A108;TCGA Breast Carcinoma;Normal-like;Positive;Positive;Negative;1;3;M0;T2;N2;stage III;64;FEMALE;Alive;27.5;NA;124;DiseaseFree;27.5
808;TCGA-E2-A109;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;4;M0;T2;N0 ;stage II;64;FEMALE;Alive;46.55;NA;1172;DiseaseFree;46.55
809;TCGA-E2-A10A;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T3;N0 ;stage II;41;FEMALE;Alive;40.37;NA;352;Recurred/Progressed;2.46
810;TCGA-E2-A10B;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N1;stage II;67;FEMALE;Alive;37.48;NA;748;Recurred/Progressed;6.41
811;TCGA-E2-A10C;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N1;stage II;54;FEMALE;Alive;40.08;NA;854;DiseaseFree;40.08
812;TCGA-E2-A10E;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N1;stage II;64;FEMALE;Alive;28.42;NA;418;DiseaseFree;28.42
813;TCGA-E2-A10F;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;NA;M0;T2;N0 ;stage II;47;FEMALE;Alive;28.84;NA;360;DiseaseFree;28.84
814;TCGA-E2-A14N;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N1;stage II;37;FEMALE;Alive;47.11;NA;1350;DiseaseFree;47.11
815;TCGA-E2-A14O;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T3;N1;stage III;76;FEMALE;Alive;44.65;NA;1173;DiseaseFree;44.65
816;TCGA-E2-A14P;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;1;1;M0;T2;N3;stage III;79;FEMALE;Alive;40.93;NA;487;DiseaseFree;40.93
817;TCGA-E2-A14Q;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T2;N1;stage II;50;FEMALE;Alive;38.21;NA;974;DiseaseFree;38.21
818;TCGA-E2-A14R;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;62;FEMALE;Alive;38.57;NA;845;Recurred/Progressed;31.9
819;TCGA-E2-A14S;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T1;N0;stage I;65;FEMALE;Alive;33.15;NA;834;DiseaseFree;33.15
820;TCGA-E2-A14T;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;52;FEMALE;Alive;33.28;NA;890;DiseaseFree;33.28
821;TCGA-E2-A14U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;74;FEMALE;Alive;43.3;NA;838;DiseaseFree;43.3
822;TCGA-E2-A14V;TCGA Breast Carcinoma;HER2-enriched;Positive;Positive;Positive;4;1;M0;T2;N1;stage II;53;FEMALE;Alive;34.23;NA;748;DiseaseFree;34.23
823;TCGA-E2-A14W;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Positive;2;4;M0;T2;N0;stage II;78;MALE;Alive;32;NA;834;DiseaseFree;32
824;TCGA-E2-A14X;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N2;stage III;55;FEMALE;Alive;31.93;NA;692;DiseaseFree;31.93
825;TCGA-E2-A14Y;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Positive;2;3;M0;T2;N0;stage II;35;FEMALE;Alive;28.58;NA;688;DiseaseFree;28.58
826;TCGA-E2-A14Z;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N0;stage I;64;FEMALE;Dead;18.5;NA;518;Recurred/Progressed;6.18
827;TCGA-E2-A150;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;48;FEMALE;Alive;25.39;NA;591;DiseaseFree;25.39
828;TCGA-E2-A152;TCGA Breast Carcinoma;HER2-enriched;Positive;Negative;Positive;1;1;M0;T1;N0;stage I;56;FEMALE;Alive;27.1;NA;588;Recurred/Progressed;2.73
829;TCGA-E2-A153;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T1;N1;stage II;51;FEMALE;Alive;23.23;NA;586;DiseaseFree;23.23
830;TCGA-E2-A154;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0;stage I;68;FEMALE;Alive;19.42;NA;325;DiseaseFree;19.42
831;TCGA-E2-A155;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;3;4;M0;T2;N1;stage II;58;FEMALE;Alive;21.02;NA;553;DiseaseFree;21.02
832;TCGA-E2-A156;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0;stage I;61;FEMALE;Alive;23.85;NA;481;DiseaseFree;23.85
833;TCGA-E2-A158;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T1;N1;stage II;43;FEMALE;Alive;14.78;NA;450;DiseaseFree;14.78
834;TCGA-E2-A159;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;50;FEMALE;Alive;25.03;NA;515;DiseaseFree;25.03
835;TCGA-E2-A15A;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N3;stage III;45;FEMALE;Alive;23.32;NA;502;DiseaseFree;23.32
836;TCGA-E2-A15A;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;4;M0;T2;N3;stage III;45;FEMALE;Alive;23.32;NA;502;DiseaseFree;23.32
837;TCGA-E2-A15C;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0;stage I;61;FEMALE;Alive;22.8;NA;497;DiseaseFree;22.8
838;TCGA-E2-A15D;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;NA;M0;T2;N0;stage II;47;FEMALE;Alive;17.28;NA;316;DiseaseFree;17.28
839;TCGA-E2-A15E;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;2;3;M0;T1;N1;stage II;40;FEMALE;Alive;20.7;NA;518;DiseaseFree;20.7
840;TCGA-E2-A15E;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;2;3;M0;T1;N1;stage II;40;FEMALE;Alive;20.7;NA;518;DiseaseFree;20.7
841;TCGA-E2-A15F;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;64;FEMALE;Alive;21.62;NA;469;DiseaseFree;21.62
842;TCGA-E2-A15G;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;1;3;M0;T2;N0;stage II;76;FEMALE;Alive;18.2;NA;316;DiseaseFree;18.2
843;TCGA-E2-A15H;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;2;3;M0;T1;N1;stage II;38;FEMALE;Alive;12.91;NA;42;DiseaseFree;12.91
844;TCGA-E2-A15I;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;44;FEMALE;Alive;17.41;NA;411;DiseaseFree;17.41
845;TCGA-E2-A15J;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;N0;stage I;51;FEMALE;Alive;19.38;NA;464;DiseaseFree;19.38
846;TCGA-E2-A15K;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N1;stage II;58;FEMALE;Alive;9.03;NA;34;DiseaseFree;9.03
847;TCGA-E2-A15K;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;4;M0;T2;N1;stage II;58;FEMALE;Alive;9.03;NA;34;DiseaseFree;9.03
848;TCGA-E2-A15L;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;65;FEMALE;Alive;20.57;NA;331;DiseaseFree;20.57
849;TCGA-E2-A15M;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;1;3;M0;T2;N0;stage II;66;FEMALE;Dead;11.04;NA;235;NA;NA
850;TCGA-E2-A15O;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T1;NX;stage I;89;FEMALE;Alive;13.01;NA;396;DiseaseFree;13.01
851;TCGA-E2-A15P;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0;stage I;61;FEMALE;Alive;19.55;NA;315;DiseaseFree;19.55
852;TCGA-E2-A15R;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;3;3;M0;T1;N1;stage II;64;FEMALE;Alive;17.05;NA;330;DiseaseFree;17.05
853;TCGA-E2-A15S;TCGA Breast Carcinoma;Luminal B;Positive;Negative;Negative;4;NA;M0;T2;N1;stage II;34;FEMALE;Alive;14.06;NA;274;DiseaseFree;14.06
854;TCGA-E2-A15T;TCGA Breast Carcinoma;Luminal B;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;65;FEMALE;Alive;14.98;NA;267;DiseaseFree;14.98
855;TCGA-E2-A1AZ;TCGA Breast Carcinoma;Basal-like;Negative;Negative;Negative;5;NA;M0;T2;N1;stage II;63;FEMALE;Alive;76.51;NA;1965;DiseaseFree;76.51
856;TCGA-E2-A1B0;TCGA Breast Carcinoma;HER2-enriched;Negative;Negative;Positive;5;2;M0;T2;N2;stage III;50;FEMALE;Alive;53.58;NA;1271;DiseaseFree;53.58
857;TCGA-E2-A1B1;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Positive;5;3;M0;T2;N1;stage II;45;FEMALE;Alive;52.99;NA;1361;DiseaseFree;52.99
858;TCGA-E2-A1B4;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N2;stage III;74;FEMALE;Dead;32.98;NA;911;NA;NA
859;TCGA-E2-A1B5;TCGA Breast Carcinoma;Basal-like;Positive;Positive;Negative;1;3;M0;T2;N0;stage II;46;FEMALE;Alive;32.33;NA;774;DiseaseFree;32.33
860;TCGA-E2-A1B6;TCGA Breast Carcinoma;Luminal A;Negative;Negative;Negative;5;2;M0;T2;N0;stage II;44;FEMALE;Alive;28.48;NA;338;DiseaseFree;28.48
861;TCGA-E2-A1BC;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;2;3;M0;T1;N0;stage I;63;FEMALE;Alive;16.46;NA;297;DiseaseFree;16.46
862;TCGA-E2-A1BD;TCGA Breast Carcinoma;Luminal A;Positive;Positive;Negative;4;3;M0;T2;N0;stage II;53;FEMALE;Alive;17.08;NA;317;DiseaseFree;17.08
863;TCGA-E2-A1IE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N1;stage II;61;FEMALE;Alive;38.27;NA;983;DiseaseFree;38.27
864;TCGA-E2-A1IF;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T1;N0;stage I;74;FEMALE;Alive;37.39;NA;956;DiseaseFree;37.39
865;TCGA-E2-A1IG;TCGA Breast Carcinoma;NA;Positive;Positive;Not Available;4;NA;M0;T2;N1;stage II;45;FEMALE;Alive;32.75;NA;755;DiseaseFree;32.75
866;TCGA-E2-A1IH;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;80;FEMALE;Alive;33.71;NA;658;DiseaseFree;33.71
867;TCGA-E2-A1II;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;5;NA;M0;T1;N0;stage I;51;FEMALE;Alive;33.67;NA;850;DiseaseFree;33.67
868;TCGA-E2-A1IJ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N0;stage I;57;FEMALE;Alive;28.42;NA;725;DiseaseFree;28.42
869;TCGA-E2-A1IK;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N1;stage II;71;FEMALE;Alive;22.63;NA;519;DiseaseFree;22.63
870;TCGA-E2-A1IL;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N1;stage II;78;FEMALE;Alive;3.88;NA;14;DiseaseFree;3.88
871;TCGA-E2-A1IN;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N0;stage I;60;FEMALE;Alive;22.17;NA;392;DiseaseFree;22.17
872;TCGA-E2-A1IO;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;37;FEMALE;Alive;20.96;NA;449;DiseaseFree;20.96
873;TCGA-E2-A1IP;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;NA;NA;;;;;NA;;;NA;NA;NA;;NA
874;TCGA-E2-A1IU;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0 (mol+);stage I;60;FEMALE;Alive;11.07;NA;127;DiseaseFree;11.07
875;TCGA-E2-A1L6;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T1;N1;stage II;44;FEMALE;Alive;54.14;NA;1312;DiseaseFree;54.14
876;TCGA-E2-A1L7;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;2;NA;M0;T2;N2;stage III;40;FEMALE;Alive;27.4;NA;633;DiseaseFree;27.4
877;TCGA-E2-A1L8;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;52;FEMALE;Alive;39.59;NA;1015;DiseaseFree;39.59
878;TCGA-E2-A1L9;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N1;stage II;40;FEMALE;Alive;19.65;NA;388;DiseaseFree;19.65
879;TCGA-E2-A1LA;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T1;N1;stage II;59;FEMALE;Alive;24.57;NA;463;DiseaseFree;24.57
880;TCGA-E2-A1LB;TCGA Breast Carcinoma;NA;Negative;Negative;Positive;4;NA;M0;T2;N1;stage II;41;FEMALE;Alive;40.44;NA;972;DiseaseFree;40.44
881;TCGA-E2-A1LE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;71;FEMALE;Dead;28.88;879;NA;Recurred/Progressed;11.86
882;TCGA-E2-A1LG;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0;stage II;50;FEMALE;Alive;18.86;NA;350;DiseaseFree;18.86
883;TCGA-E2-A1LH;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T1;N0;stage I;59;FEMALE;Alive;106.67;NA;2876;DiseaseFree;106.67
884;TCGA-E2-A1LI;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;M0;T2;N1;stage II;57;FEMALE;Alive;102.53;NA;2750;DiseaseFree;102.53
885;TCGA-E2-A1LK;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;3;NA;M0;T4;N3;stage III;84;FEMALE;Dead;8.74;266;NA;Recurred/Progressed;5.09
886;TCGA-E2-A1LL;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;1;NA;MX;T3;N2;stage III;73;FEMALE;Alive;43;NA;1014;Recurred/Progressed;42.81
887;TCGA-E2-A1LS;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;3;NA;M0;T1;N0;stage I;46;FEMALE;Alive;15.44;NA;239;DiseaseFree;15.44
888;TCGA-E2-A2P5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;78;FEMALE;Alive;16.92;NA;326;DiseaseFree;16.92
889;TCGA-E2-A2P6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;77;FEMALE;Alive;5.52;NA;168;DiseaseFree;5.52
890;TCGA-E2-A3DX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;43;FEMALE;Alive;15.7;NA;217;DiseaseFree;15.7
891;TCGA-E2-A56Z;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;69;FEMALE;Alive;7.19;NA;219;DiseaseFree;7.19
892;TCGA-E2-A570;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N1;stage I;47;FEMALE;Alive;18.04;NA;549;DiseaseFree;18.04
893;TCGA-E2-A572;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N2;stage III;72;FEMALE;Alive;27.3;NA;831;DiseaseFree;27.3
894;TCGA-E2-A573;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0;stage I;48;FEMALE;Alive;22.24;NA;677;DiseaseFree;22.24
895;TCGA-E2-A574;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;44;FEMALE;Alive;19.88;NA;605;DiseaseFree;19.88
896;TCGA-E2-A576;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
897;TCGA-E2-A9RU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
898;TCGA-E9-A1N3;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;4;NA;M0;T1;N2;stage III;70;FEMALE;Alive;0;NA;0;DiseaseFree;0
899;TCGA-E9-A1N4;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N2;stage III;41;FEMALE;Alive;19.19;NA;5;DiseaseFree;19.19
900;TCGA-E9-A1N5;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;45;FEMALE;Alive;36.79;NA;0;DiseaseFree;36.79
901;TCGA-E9-A1N6;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;M0;T2;N1;stage II;52;FEMALE;Alive;13.47;NA;0;DiseaseFree;13.47
902;TCGA-E9-A1N8;TCGA Breast Carcinoma;NA;Negative;Not Performed;Negative;5;NA;M0;T2;N0;stage II;48;FEMALE;Alive;11.99;NA;0;DiseaseFree;11.99
903;TCGA-E9-A1N9;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;1;NA;M0;T2;N0;stage II;58;FEMALE;Alive;13.11;NA;0;DiseaseFree;13.11
904;TCGA-E9-A1NA;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;M0;T2;N0;stage II;58;FEMALE;Alive;36.53;NA;0;DiseaseFree;36.53
905;TCGA-E9-A1NC;TCGA Breast Carcinoma;NA;Negative;Positive;Negative;5;NA;M0;T2;N1;stage II;61;FEMALE;Alive;23.26;NA;0;DiseaseFree;23.26
906;TCGA-E9-A1ND;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N1;stage II;75;FEMALE;Alive;12.58;NA;0;DiseaseFree;12.58
907;TCGA-E9-A1NE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;28;FEMALE;Alive;35.74;NA;0;DiseaseFree;35.74
908;TCGA-E9-A1NF;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;60;FEMALE;Alive;20.04;NA;0;Recurred/Progressed;2.96
909;TCGA-E9-A1NG;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N0;stage II;62;FEMALE;Dead;25.82;NA;0;NA;NA
910;TCGA-E9-A1NH;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;71;FEMALE;Alive;0;NA;0;DiseaseFree;0
911;TCGA-E9-A1NI;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N0;stage II;51;FEMALE;Alive;9.86;NA;-7;DiseaseFree;9.86
912;TCGA-E9-A1QZ;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T2;N0;stage II;61;FEMALE;Alive;11.89;NA;0;DiseaseFree;11.89
913;TCGA-E9-A1R0;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;4;NA;M0;T1;N1;stage II;58;FEMALE;Alive;14.29;NA;0;DiseaseFree;14.29
914;TCGA-E9-A1R2;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;4;NA;MX;T2;N3;stage III;51;FEMALE;Alive;0.62;NA;19;DiseaseFree;0.62
915;TCGA-E9-A1R3;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T2;N3;stage III;70;FEMALE;Alive;2.1;NA;64;DiseaseFree;2.1
916;TCGA-E9-A1R4;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T1;N0;stage I;66;FEMALE;Alive;6.11;NA;29;DiseaseFree;6.11
917;TCGA-E9-A1R5;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T1;N0;stage I;63;FEMALE;Alive;1.38;NA;42;DiseaseFree;1.38
918;TCGA-E9-A1R6;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N0;stage II;63;FEMALE;Alive;2.76;NA;84;DiseaseFree;2.76
919;TCGA-E9-A1R7;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N0;stage II;64;FEMALE;Alive;21.19;NA;34;DiseaseFree;21.19
920;TCGA-E9-A1RA;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T1;N0;stage I;48;FEMALE;Alive;19.97;NA;29;DiseaseFree;19.97
921;TCGA-E9-A1RB;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T2;N0;stage II;40;FEMALE;Dead;32.06;NA;21;NA;NA
922;TCGA-E9-A1RC;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T4;N3;stage III;56;FEMALE;Alive;40.21;NA;1224;DiseaseFree;40.21
923;TCGA-E9-A1RD;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N0;stage II;67;FEMALE;Alive;0.66;NA;20;DiseaseFree;0.66
924;TCGA-E9-A1RE;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N2;stage III;74;FEMALE;Alive;25.66;NA;47;DiseaseFree;25.66
925;TCGA-E9-A1RF;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N2;stage III;68;FEMALE;Alive;6.57;NA;38;DiseaseFree;6.57
926;TCGA-E9-A1RG;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;2;NA;M0;T1;N2;stage III;62;FEMALE;Alive;21.25;NA;35;DiseaseFree;21.25
927;TCGA-E9-A1RH;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;4;NA;M0;T2;N0;stage II;63;FEMALE;Alive;34.56;NA;14;DiseaseFree;34.56
928;TCGA-E9-A1RI;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Not Available;1;NA;M0;T1;N2;stage III;43;FEMALE;Alive;35.61;NA;48;DiseaseFree;35.61
929;TCGA-E9-A226;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T2;N2;stage III;45;FEMALE;Alive;34.1;NA;16;Recurred/Progressed;25.95
930;TCGA-E9-A227;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;42;FEMALE;Alive;0.79;NA;24;DiseaseFree;0.79
931;TCGA-E9-A228;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Positive;3;NA;M0;T2;N1;stage II;58;FEMALE;Alive;12.52;NA;0;DiseaseFree;12.52
932;TCGA-E9-A229;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T1;N0;stage I;37;FEMALE;Alive;13.3;NA;0;DiseaseFree;13.3
933;TCGA-E9-A22A;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;3;NA;M0;T2;N0;stage II;74;FEMALE;Alive;23.39;NA;0;DiseaseFree;23.39
934;TCGA-E9-A22B;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;3;NA;M0;T1;N0;stage I;71;FEMALE;Alive;22.73;NA;0;DiseaseFree;22.73
935;TCGA-E9-A22D;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;M0;T2;N0;stage II;38;FEMALE;Alive;0;NA;0;DiseaseFree;0
936;TCGA-E9-A22E;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N2;stage III;56;FEMALE;Alive;12.88;NA;0;DiseaseFree;12.88
937;TCGA-E9-A22G;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;3;NA;M0;T2;N0;stage II;47;FEMALE;Alive;0;NA;0;DiseaseFree;0
938;TCGA-E9-A22H;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T2;N1;stage II;42;FEMALE;Alive;24.08;NA;0;DiseaseFree;24.08
939;TCGA-E9-A243;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;5;NA;M0;T2;N0 ;stage II;52;FEMALE;Alive;17.05;NA;43;Recurred/Progressed;10.02
940;TCGA-E9-A244;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;5;NA;M0;T2;N0 ;stage II;54;FEMALE;Alive;0.69;NA;21;DiseaseFree;0.69
941;TCGA-E9-A245;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;2;NA;M0;T2;N1;stage II;47;FEMALE;Dead;NA;NA;26;NA;NA
942;TCGA-E9-A247;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;3;NA;M0;T1;N0 ;stage I;59;FEMALE;Alive;27.2;NA;13;DiseaseFree;27.2
943;TCGA-E9-A248;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;1;NA;M0;T2;N0 ;stage II;51;FEMALE;Alive;1.94;NA;22;DiseaseFree;1.94
944;TCGA-E9-A249;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;4;NA;M0;T2;N0 ;stage II;45;FEMALE;Alive;0.95;NA;29;DiseaseFree;0.95
945;TCGA-E9-A24A;TCGA Breast Carcinoma;NA;Not Performed;Not Performed;Negative;2;NA;M0;T1;N1;stage II;69;FEMALE;Alive;12.55;NA;11;DiseaseFree;12.55
946;TCGA-E9-A295;TCGA Breast Carcinoma;NA;NA;NA;NA;4;NA;M0;T2;N0 ;stage II;71;FEMALE;Alive;0.72;NA;22;DiseaseFree;0.72
947;TCGA-E9-A2JS;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;72;FEMALE;Dead;29.7;NA;13;Recurred/Progressed;17.21
948;TCGA-E9-A2JT;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;63;FEMALE;Alive;0.76;NA;23;DiseaseFree;0.76
949;TCGA-E9-A3HO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;49;FEMALE;Alive;26.05;NA;19;DiseaseFree;26.05
950;TCGA-E9-A3Q9;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;78;FEMALE;Alive;18.4;NA;31;DiseaseFree;18.4
951;TCGA-E9-A3QA;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;33;FEMALE;Alive;0.62;NA;19;DiseaseFree;0.62
952;TCGA-E9-A3X8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;48;FEMALE;Alive;15.7;NA;23;DiseaseFree;15.7
953;TCGA-E9-A54X;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N0 ;stage I;85;FEMALE;Alive;0;NA;0;DiseaseFree;0
954;TCGA-E9-A54Y;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N2;stage III;63;FEMALE;Alive;0.23;NA;7;DiseaseFree;0.23
955;TCGA-E9-A5FK;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N3;stage III;60;FEMALE;Alive;0.39;NA;12;DiseaseFree;0.39
956;TCGA-E9-A5FL;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N0;stage II;65;FEMALE;Alive;0.26;NA;8;DiseaseFree;0.26
957;TCGA-E9-A5UO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;41;FEMALE;Alive;0.23;NA;7;DiseaseFree;0.23
958;TCGA-E9-A5UP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;63;FEMALE;Alive;0;NA;0;DiseaseFree;0
959;TCGA-E9-A6HE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
960;TCGA-EW-A1IW;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;3;NA;MX;T2;N1;stage II;80;FEMALE;Alive;12.19;NA;252;DiseaseFree;12.19
961;TCGA-EW-A1IX;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T1;N1;stage II;48;FEMALE;Alive;39.68;NA;1082;DiseaseFree;39.68
962;TCGA-EW-A1IY;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T1;N0;stage I;38;FEMALE;Alive;8.48;NA;258;DiseaseFree;8.48
963;TCGA-EW-A1IZ;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T2;N2;stage III;53;FEMALE;Alive;18.2;NA;260;DiseaseFree;18.2
964;TCGA-EW-A1J1;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;38;FEMALE;Alive;18.89;NA;282;DiseaseFree;18.89
965;TCGA-EW-A1J2;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T1;N1;stage II;50;FEMALE;Alive;13.24;NA;140;DiseaseFree;13.24
966;TCGA-EW-A1J3;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;4;NA;M0;T1;N0;stage I;61;FEMALE;Alive;16.56;NA;252;DiseaseFree;16.56
967;TCGA-EW-A1J5;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T3;N0 ;stage II;59;FEMALE;Alive;15.67;NA;227;DiseaseFree;15.67
968;TCGA-EW-A1J6;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;5;NA;M0;T1;N0 ;stage I;70;FEMALE;Alive;28.75;NA;595;DiseaseFree;28.75
969;TCGA-EW-A1OV;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;4;NA;MX;T2;N1;stage II;56;FEMALE;Alive;25.92;NA;523;DiseaseFree;25.92
970;TCGA-EW-A1OW;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;MX;T2;N0;stage II;58;FEMALE;Alive;22.8;NA;464;DiseaseFree;22.8
971;TCGA-EW-A1OX;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;3;NA;MX;T2;N0;stage II;43;FEMALE;Alive;29.93;NA;562;DiseaseFree;29.93
972;TCGA-EW-A1OY;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;MX;T2;N0;stage II;63;FEMALE;Alive;29.83;NA;593;DiseaseFree;29.83
973;TCGA-EW-A1OZ;TCGA Breast Carcinoma;NA;Positive;Negative;Positive;4;NA;M0;T2;N0 ;stage II;56;FEMALE;Alive;40.37;NA;941;DiseaseFree;40.37
974;TCGA-EW-A1P0;TCGA Breast Carcinoma;NA;Positive;Negative;Negative;5;NA;MX;T2;N1;stage II;55;FEMALE;Alive;41.1;NA;1121;Recurred/Progressed;35.94
975;TCGA-EW-A1P1;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;1;NA;MX;T2;N3;stage III;68;FEMALE;Alive;39.75;NA;920;Recurred/Progressed;33.31
976;TCGA-EW-A1P3;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T2;N0;stage II;48;FEMALE;Alive;52.92;NA;987;DiseaseFree;52.92
977;TCGA-EW-A1P4;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;43;FEMALE;Alive;29.8;NA;501;DiseaseFree;29.8
978;TCGA-EW-A1P5;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;77;FEMALE;Alive;23.09;NA;365;DiseaseFree;23.09
979;TCGA-EW-A1P6;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;2;NA;M0;T2;N1;stage II;64;FEMALE;Alive;18.46;NA;312;DiseaseFree;18.46
980;TCGA-EW-A1P7;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N0 ;stage II;59;FEMALE;Alive;30.06;NA;635;Recurred/Progressed;23.95
981;TCGA-EW-A1P8;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;M0;T2;N3;stage III;58;FEMALE;Dead;7.85;239;NA;Recurred/Progressed;6.8
982;TCGA-EW-A1PA;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;4;NA;M0;T2;N1;stage II;59;FEMALE;Alive;18.89;NA;267;DiseaseFree;18.89
983;TCGA-EW-A1PB;TCGA Breast Carcinoma;NA;Negative;Negative;Negative;5;NA;MX;T3;N1;stage III;70;FEMALE;Alive;19.97;NA;608;DiseaseFree;19.97
984;TCGA-EW-A1PC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0 ;stage II;66;FEMALE;Alive;6.14;NA;187;DiseaseFree;6.14
985;TCGA-EW-A1PD;TCGA Breast Carcinoma;NA;Positive;Positive;Positive;2;NA;M0;T1;N1;stage II;61;MALE;Alive;13.93;NA;175;DiseaseFree;13.93
986;TCGA-EW-A1PE;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N1;stage II;56;FEMALE;Alive;10.51;NA;107;DiseaseFree;10.51
987;TCGA-EW-A1PF;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;M0;T1;N0;stage I;50;FEMALE;Alive;14.42;NA;140;DiseaseFree;14.42
988;TCGA-EW-A1PG;TCGA Breast Carcinoma;NA;Positive;Positive;Negative;1;NA;MX;T2;N1;stage II;53;FEMALE;Alive;34.53;NA;876;DiseaseFree;34.53
989;TCGA-EW-A1PH;TCGA Breast Carcinoma;NA;Negative;Negative;Not Available;5;NA;M0;T1;N1;stage II;52;FEMALE;Alive;19.94;NA;140;DiseaseFree;19.94
990;TCGA-EW-A2FR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N3;stage III;59;FEMALE;Alive;54.96;NA;1120;DiseaseFree;54.96
991;TCGA-EW-A2FS;TCGA Breast Carcinoma;NA;Positive;Negative;NA;4;NA;MX;T2;N1;stage II;41;FEMALE;Alive;52.69;NA;1173;DiseaseFree;52.69
992;TCGA-EW-A2FV;TCGA Breast Carcinoma;NA;Positive;Positive;NA;4;NA;MX;T3;N3;stage III;39;FEMALE;Alive;25.89;NA;239;DiseaseFree;25.89
993;TCGA-EW-A2FW;TCGA Breast Carcinoma;NA;Positive;Positive;NA;2;NA;MX;T2;N0 ;stage II;52;FEMALE;Alive;22.08;NA;191;DiseaseFree;22.08
994;TCGA-EW-A3E8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;60;FEMALE;Alive;21.25;NA;647;DiseaseFree;21.25
995;TCGA-EW-A3U0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N1;stage III;61;FEMALE;Alive;17.48;NA;229;DiseaseFree;17.48
996;TCGA-EW-A423;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;75;FEMALE;Alive;10.15;NA;309;DiseaseFree;10.15
997;TCGA-EW-A424;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N1;stage II;51;FEMALE;Alive;10.58;NA;322;DiseaseFree;10.58
998;TCGA-EW-A6S9;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
999;TCGA-EW-A6SA;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1000;TCGA-EW-A6SB;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1001;TCGA-EW-A6SC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1002;TCGA-EW-A6SD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1003;TCGA-GI-A2C8;TCGA Breast Carcinoma;NA;NA;NA;NA;3;NA;MX;T4;N0;stage III;63;FEMALE;Alive;7.39;NA;225;DiseaseFree;7.39
1004;TCGA-GI-A2C9;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;58;FEMALE;Alive;109.79;NA;711;DiseaseFree;109.79
1005;TCGA-GM-A2D9;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T1;N0 ;stage I;69;FEMALE;Dead;59.53;1812;NA;NA;NA
1006;TCGA-GM-A2DA;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T2;N1;stage II;46;FEMALE;Alive;194.12;NA;5909;DiseaseFree;194.12
1007;TCGA-GM-A2DB;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;M0;T2;N0 ;stage II;62;FEMALE;Alive;53.09;NA;1616;DiseaseFree;53.09
1008;TCGA-GM-A2DC;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T1;N1;stage II;57;FEMALE;Alive;53.48;NA;1628;DiseaseFree;53.48
1009;TCGA-GM-A2DD;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;M0;T1;N0 ;stage I;53;FEMALE;Alive;43;NA;1309;DiseaseFree;43
1010;TCGA-GM-A2DF;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;M0;T1;N1;stage II;53;FEMALE;Alive;42.67;NA;1299;DiseaseFree;42.67
1011;TCGA-GM-A2DH;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;M0;T1;N0 ;stage I;58;FEMALE;Alive;42.25;NA;1286;DiseaseFree;42.25
1012;TCGA-GM-A2DI;TCGA Breast Carcinoma;NA;Negative;Negative;NA;NA;NA;M0;T1;N0 ;stage I;52;FEMALE;Alive;61.86;NA;1883;DiseaseFree;61.86
1013;TCGA-GM-A2DK;TCGA Breast Carcinoma;NA;Positive;Negative;NA;NA;NA;M0;T1;N0 ;stage I;58;FEMALE;Alive;62.29;NA;1896;DiseaseFree;62.29
1014;TCGA-GM-A2DL;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T1;N0 ;stage I;50;FEMALE;Alive;90.77;NA;2763;DiseaseFree;90.77
1015;TCGA-GM-A2DM;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T2;N0 ;stage II;57;FEMALE;Alive;76.58;NA;2331;DiseaseFree;76.58
1016;TCGA-GM-A2DN;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T2;N0 ;stage II;58;FEMALE;Alive;77.27;NA;2352;DiseaseFree;77.27
1017;TCGA-GM-A2DO;TCGA Breast Carcinoma;NA;Positive;Positive;NA;NA;NA;M0;T1;N0 ;stage I;54;FEMALE;Alive;53.32;NA;1623;DiseaseFree;53.32
1018;TCGA-GM-A3NW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;63;FEMALE;Alive;110.41;NA;2982;DiseaseFree;110.41
1019;TCGA-GM-A3NY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;72;FEMALE;Alive;38.17;NA;743;DiseaseFree;38.17
1020;TCGA-GM-A3XG;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N1;stage III;46;FEMALE;Alive;32.26;NA;982;DiseaseFree;32.26
1021;TCGA-GM-A3XL;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;49;FEMALE;Alive;69.25;NA;1717;DiseaseFree;69.25
1022;TCGA-GM-A3XN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T1;N2;stage III;44;FEMALE;Alive;53.91;NA;1641;DiseaseFree;53.91
1023;TCGA-GM-A4E0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;67;FEMALE;Alive;57.59;NA;1753;DiseaseFree;57.59
1024;TCGA-GM-A5PV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;63;FEMALE;Alive;13.53;NA;412;DiseaseFree;13.53
1025;TCGA-GM-A5PX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;65;FEMALE;Alive;18.1;NA;551;DiseaseFree;18.1
1026;TCGA-HN-A2NL;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1027;TCGA-HN-A2OB;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1028;TCGA-JL-A3YW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;49;FEMALE;Alive;11.83;NA;360;DiseaseFree;11.83
1029;TCGA-JL-A3YX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0;stage II;46;FEMALE;Alive;11.56;NA;352;DiseaseFree;11.56
1030;TCGA-LD-A66U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;44;FEMALE;Alive;8.28;NA;252;DiseaseFree;8.28
1031;TCGA-LD-A74U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T3;N3;stage III;79;FEMALE;Alive;6.67;NA;203;DiseaseFree;6.67
1032;TCGA-LD-A7W5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1033;TCGA-LD-A7W6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;54;FEMALE;Alive;4.6;NA;140;DiseaseFree;4.6
1034;TCGA-LD-A9QF;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1035;TCGA-LL-A440;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0 ;stage I;61;FEMALE;Alive;0.66;NA;20;DiseaseFree;0.66
1036;TCGA-LL-A441;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;62;FEMALE;Alive;2.99;NA;91;DiseaseFree;2.99
1037;TCGA-LL-A442;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0 ;stage II;56;FEMALE;Alive;3.58;NA;109;DiseaseFree;3.58
1038;TCGA-LL-A50Y;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;84;FEMALE;Alive;6.9;NA;210;DiseaseFree;6.9
1039;TCGA-LL-A5YL;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;64;FEMALE;Alive;5.55;NA;169;DiseaseFree;5.55
1040;TCGA-LL-A5YM;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T4;NX;stage III;88;FEMALE;Alive;4.7;NA;143;DiseaseFree;4.7
1041;TCGA-LL-A5YN;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N0 ;stage II;46;FEMALE;Alive;3.65;NA;111;DiseaseFree;3.65
1042;TCGA-LL-A5YO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;50;FEMALE;Alive;3.19;NA;97;DiseaseFree;3.19
1043;TCGA-LL-A5YP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;49;FEMALE;Alive;3.25;NA;99;DiseaseFree;3.25
1044;TCGA-LL-A6FP;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1045;TCGA-LL-A6FQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1046;TCGA-LL-A6FR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0 ;stage II;50;FEMALE;Alive;3.88;NA;118;DiseaseFree;3.88
1047;TCGA-LL-A73Y;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1048;TCGA-LL-A73Z;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1049;TCGA-LL-A740;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0 ;stage I;61;FEMALE;Alive;4.5;NA;137;DiseaseFree;4.5
1050;TCGA-LL-A7SZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1051;TCGA-LL-A7T0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1052;TCGA-LL-A8F5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1053;TCGA-LL-A9Q3;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1054;TCGA-LQ-A4E4;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N1;stage III;73;FEMALE;Alive;15.9;NA;484;DiseaseFree;15.9
1055;TCGA-MS-A51U;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;44;FEMALE;Alive;2.79;NA;85;DiseaseFree;2.79
1056;TCGA-OK-A5Q2;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;59;FEMALE;Alive;2.1;NA;64;DiseaseFree;2.1
1057;TCGA-OL-A5D6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;71;FEMALE;Alive;12.65;NA;385;DiseaseFree;12.65
1058;TCGA-OL-A5D7;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;70;FEMALE;Alive;46.52;NA;1416;DiseaseFree;46.52
1059;TCGA-OL-A5D8;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N0;stage II;40;FEMALE;Alive;7.52;NA;229;DiseaseFree;7.52
1060;TCGA-OL-A5DA;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;61;FEMALE;Alive;44.58;NA;1357;DiseaseFree;44.58
1061;TCGA-OL-A5RU;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage II;63;FEMALE;Alive;27.63;NA;841;DiseaseFree;27.63
1062;TCGA-OL-A5RV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N3;stage III;43;FEMALE;Alive;24.08;NA;733;DiseaseFree;24.08
1063;TCGA-OL-A5RW;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage II;40;FEMALE;Alive;26.18;NA;797;DiseaseFree;26.18
1064;TCGA-OL-A5RX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;51;FEMALE;Alive;16.85;NA;513;DiseaseFree;16.85
1065;TCGA-OL-A5RY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage I;52;FEMALE;Alive;14.09;NA;429;DiseaseFree;14.09
1066;TCGA-OL-A5RZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;57;FEMALE;Alive;10.28;NA;313;DiseaseFree;10.28
1067;TCGA-OL-A5S0;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;66;FEMALE;Alive;9.79;NA;298;DiseaseFree;9.79
1068;TCGA-OL-A66H;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage I;74;FEMALE;Alive;14.75;NA;449;DiseaseFree;14.75
1069;TCGA-OL-A66I;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N1;stage II;36;FEMALE;Alive;23.69;NA;721;DiseaseFree;23.69
1070;TCGA-OL-A66J;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;80;FEMALE;Alive;54.47;NA;1658;DiseaseFree;54.47
1071;TCGA-OL-A66K;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;72;FEMALE;Alive;33.87;NA;1031;DiseaseFree;33.87
1072;TCGA-OL-A66L;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T1;N0;stage I;71;FEMALE;Alive;31.04;NA;945;DiseaseFree;31.04
1073;TCGA-OL-A66N;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T3;N3;stage III;59;FEMALE;Alive;18.2;NA;554;DiseaseFree;18.2
1074;TCGA-OL-A66O;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N1;stage II;39;FEMALE;Alive;7.23;NA;220;DiseaseFree;7.23
1075;TCGA-OL-A66P;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0;stage II;75;FEMALE;Alive;4.43;NA;135;DiseaseFree;4.43
1076;TCGA-OL-A6VO;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1077;TCGA-OL-A6VQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1078;TCGA-OL-A6VR;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1079;TCGA-OL-A97C;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1080;TCGA-PE-A5DC;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1081;TCGA-PE-A5DD;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1082;TCGA-PE-A5DE;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1083;TCGA-PL-A8LV;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1084;TCGA-PL-A8LX;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1085;TCGA-PL-A8LY;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1086;TCGA-PL-A8LZ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1087;TCGA-S3-A6ZF;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1088;TCGA-S3-A6ZG;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;M0;T2;N1;stage II;71;FEMALE;Alive;6.8;NA;207;DiseaseFree;6.8
1089;TCGA-S3-A6ZH;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1090;TCGA-S3-AA0Z;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1091;TCGA-S3-AA10;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1092;TCGA-S3-AA11;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1093;TCGA-S3-AA12;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1094;TCGA-S3-AA14;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1095;TCGA-S3-AA15;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1096;TCGA-S3-AA17;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1097;TCGA-UL-AAZ6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1098;TCGA-UU-A93S;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1099;TCGA-V7-A7HQ;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1100;TCGA-W8-A86G;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;MX;T2;N0 ;stage II;66;FEMALE;Alive;5.29;NA;161;DiseaseFree;5.29
1101;TCGA-WT-AB41;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1102;TCGA-WT-AB44;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1103;TCGA-XX-A899;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1104;TCGA-XX-A89A;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1105;TCGA-Z7-A8R5;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
1106;TCGA-Z7-A8R6;TCGA Breast Carcinoma;NA;NA;NA;NA;NA;NA;;;;;NA;;;NA;NA;NA;;NA
